Structural design of a stent for a percutaneous aortic heart valve by Esterhuyse, Anton
UNIVERS ITE IT •STELLENBOSCH •UNIVERS ITY
j ou kenn i s v ennoo t • you r know ledge pa r tne r
Structural Design of a Stent for a Percutaneous
Aortic Heart Valve
by
Anton Esterhuyse
Thesis presented at the University of
Stellenbosch in partial fulfilment of the
requirements for the degree of
Master of Mechanical Engineering
Department of Mechanical and Mechatronic Engineering
University of Stellenbosch
Private Bag X1, 7602 Matieland, South Africa
Supervisors:
Prof C. Scheffer Mr K. van der Westhuizen
March 2009
Copyright © 2009 University of Stellenbosch
All rights reserved.
Declaration
I, the undersigned, hereby declare that the work contained in this thesis
is my own original work and that I have not previously in its entirety or
in part submitted it at any university for a degree.
Signature: . . . . . . . . . . . . . . . . . . . . . . . . .
A.H. Esterhuyse
Date: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ii
Abstract
Structural Design of a Stent for a Percutaneous Aortic
Heart Valve
A.H. Esterhuyse
Department of Mechanical and Mechatronic Engineering
University of Stellenbosch
Private Bag X1, 7602 Matieland, South Africa
Thesis: MEng (Mech)
March 2009
Elderly patients suffering from aortic valvular dysfunction are often de-
nied aortic valve replacement due to the fact that they are classified as
too old and fragile to handle the physical stress of open-heart surgery
and cardio-pulmonary bypass. There exists a need for an alternative so-
lution which places less physical stress on the body. The development
of a percutaneous aortic heart valve (PAHV), which may be implanted
through a minimally invasive procedure, will provide a solution to old
and fragile patients who otherwise have a very limited life expectancy.
The development of such a device entails a costly and time-consuming
process which involves a number of phases, including a prototype de-
velopment phase, an in-vitro testing phase, an animal trial phase and a
human trial phase.
This thesis focuses on the design and analysis of the stent component
for a PAHV, suitable for implantation in sheep (animal trial phase). The
process of developing a first prototype, involved an analysis of the stent
iii
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design requirements. This analysis was followed by a concept generation
phase as well as comprehensive finite element (FE) analyses of the most
promising concepts. The objective of the FE analyses was to determine
the effects of a variation in strut width on the performance characteristics
of the concepts. Based on the results of the FE analyses, final geometries
were selected for each of the two most promising concepts. Subsequent
to the selection of the final geometries, a number of prototypeswereman-
ufactured. The prototypes were subjected to an electro-polishing process.
An experimental analysis was also conducted on the prototypes to evalu-
ate the accuracy of the (FE) simulations as well as the actual performance
of the stent prototypes.
The results of the FE analyses and experimental analyses indicated
that strut width had a substantial influence on the parameters that were
defined to characterise stent performance. The results of the analyses also
highlighted the advantages and disadvantages of each concept and aided
in identifying the concept that would be most suitable for the required
application.
Limitations of the study were identified and recommendations were
made to assist the continued research and development of the device.
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Bejaarde persone wat aan aortaklepdisfunksie ly, word dikwels aortak-
lepvervanging geweier omdat hulle as te oud en swak geklassifiseerword
om die fisiese stres van opehartchirurgie en kardiopulmonêre omleiding
te hanteer. Daar is behoefte aan ’n alternatiewe oplossing wat minder
fisiese stres op die liggaam plaas. Die ontwikkeling van ’n perkutane aor-
tahartklep (PAHK)wat met ’n prosedure wat minimale ingryping behels,
aangebring kan word, bied ’n oplossing aan persone wat oud en swak is
en andersins ’n uiters beperkte lewensverwagting het. Die ontwikkeling
van so ’n toestel is ’n duur en tydrowende proses wat heelwat fases be-
hels, insluitende ’n prototipe-ontwikkelingsfase, ’n in vitro-toetsingsfase,
’n diertoetsingsfase en ’n menstoetsingsfase.
Hierdie tesis fokus op die ontwerp en ontleding van die stentkom-
ponent vir ’n PAHK wat geskik is vir inplanting in skape (diertoets-
fase). Die proses om ’n eerste prototipe te ontwikkel het eerstens ’n
v
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ontleding van die stentontwerpvereistes behels. Hierdie ontleding is
gevolg deur ’n konsepontwikkelingsfase sowel as omvattende eindige-
elementontledings (EE-ontledings) van die mees belowende konsepte.
Die doel van die EE-ontledings was om die gevolge van ’n variasie in
stutwydte op die werksverrigtingeienskappe van die konsepte vas te
stel. Na aanleiding van die resultate van die EE-ontledings, is finale
geometrieë gekies vir elk van die twee mees belowende konsepte. Na
die keuse van die finale geometrieë, is ’n aantal prototipes vervaardig.
Die prototipes is onderwerp aan ’n elektropoleringsproses. ’n Eksper-
imentele ontleding is uitgevoer op die prototipes om die akkuraatheid
van die EE-simulasies asook die werklike werkverrigting van die stent-
prototipes te evalueer.
Die resultate van die EE-ontledings en die eksperimentele ontleding
het getoon dat stutwydte ’n wesenlike invloed op die parameters wat
vasgestel is om stentwerkverrigting te karakteriseer, gehad het. Die re-
sultate van die ontledings het ook die voordele en nadele van elke kon-
sep uitgelig en ’n bydrae gelewer om die konsep te identifiseer wat die
geskikste sou wees vir die vereiste toepassing.
Beperkings van die studie is geïdentifiseer en aanbevelings is gemaak
om die verdere navorsing en ontwikkeling van die toestel te steun.
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stent
Lload Longitudinal length before load removal
Lunload Longitudinal length after load removal
Dload Outer diameter before load removal
Dunload Outer diameter after load removal
Lcrimp The crimped longitudinal length of the stent
L f inal The final deployed longitudinal length of the stent
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Glossary of Medical Terms:
Antegrade Moving along the direction of the blood flow
Aortic arch The superior left bend of the aorta between the as-
cending and descending portions
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Catheter A small tube inserted into a body cavity to remove
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minister a drug
Coronary Refers to the circulation of blood in the blood vessels
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Diastolic Refers to the period of time during which the heart
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following angioplasty or stent placement as part of
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Percutaneous Refers to a procedure that is done through the skin
Regurgitation Blood flow in the opposite direction from normal, as
the backward flowing of blood into the heart or be-
tween heart chambers
Retrograde Moving against the direction of the blood flow
Septum The muscle wall that divides the heart chambers
Systolic Refers to the period of time during which the heart
contracts
Transseptal Refers to a procedure performed through or across
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Introduction
1.1 Background
The human heart contains four one-way valves that regulate the blood
flow to and from the four chambers of the heart. Each of the valves
consists of two or three cusps (leaflets) which prevent the back flow of
blood when they are in the closed position. The aortic valve is the out-
let valve of the main pumping chamber of the heart, the left ventricle.
It is located between the left ventricle and the aorta, the primary blood
vessel responsible for transferring blood to the rest of the cardiovascu-
lar system. During ventricular systole, the aortic valve opens to permit
blood flow from the ventricle to the aorta. During ventricular diastole,
back pressure causes the aortic valve to close, preventing the back flow
of blood from the aorta to the ventricle.
Valvular heart disease occur when one or more of the heart valves
are no longer capable of efficiently regulating the blood flow. The inlet
(mitral) and outlet (aortic) valves of the left ventricle are the two valves
that are most susceptible to disease and are responsible for the majority
of clinical heart valve diseases [6]. It is estimated that valvular disease
affects approximately 5% of the total human population [7].
There are two distinct valvular diseases that result in the malfunc-
tioning of the aortic heart valve. Aortic valvular stenosis is an artificial
1
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narrowing which restricts blood flow and causes an obstruction to the
outflow of blood from the left ventricle. Aortic valve insufficiency is a
weakening of the valve leaflets that results in regurgitation (back flow of
the blood from the aorta to the ventricle) [6]. The most common causes
for aortic stenosis are degenerative calcification of the valve leaflets, a
disease related to aging, and a congenital bicuspid aortic valve [6].
There are variousways to treat Aortic Valvular Disease, depending on
the type and severity of the disease. In some cases, medication alone is
successful in treating the disease. In other cases, valvular repair may also
be an option. If a patient is suffering from symptomatic severe degener-
ative aortic stenosis, a complete aortic valve replacement is required to
ensure the long term survival of the patient [8]. Various types of aortic
valve replacement prostheses are available, and the prosthesis selection
depends on the type and severity of the disease. These valve prostheses
include a range of mechanical valves, artificial tissue valves and animal
tissue valves. The first aortic heart valve was implanted in 1952 [9]. Over
the past 50 years, this technology has been researched and developed to
the extent that, in the modern day, the implantation of these valves are
common practice and a very high success rate is achieved.
1.2 Motivation
Despite the fact that it is performed with great success, an aortic valve
replacement procedure is a massive operation which requires cardiopul-
monary bypass (CBP) and places a major physical stress on the body.
On top of this, the procedure is very expensive to perform, about R250
000 [10]. Elderly patients suffering from aoritc valvular dysfunction are
often denied aortic valve replacement due to the fact that they are classi-
fied as too old and fragile to handle the physical stress of the procedure.
As a result of this, in South Africa alone, each year around 2700 patients
suffering from aortic valvular disease are classified as old or fragile and
are subsequently denied valve replacement [10]. These patients have no
choice but to wait for inevitable heart failure. As a result of the fact that
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Figure 1.1: Percutaneous Aortic Valve Deployment [1]
there is no solution available to these patients, over the past ten years,
research in the field of aortic valve replacements has shifted its focus to
the development of aortic valves that may be placed with minimal in-
vasive procedures. This has subsequently led to the development of the
percutaneous aortic heart valve.
A percutaneous aortic heart valve comprises of three tissue leaflets
mounted to an expandable stent frame. The expandable stent frame may
either be a balloon expandable stent or self expandable shape-memory
alloy stent. Both an antegrade and retrograde method have been devel-
oped to place the prostheses. For the retrograde approach, the prosthesis
is first crimped onto a catheter. A guide wire followed by the catheter
is then inserted into the femoral artery. The catheter is guided along the
femoral artery, into the aorta, across the aortic arch and into the desired
valve position (Figure 1.1 : B). Once in position the stent is expanded
(balloon or self-expanding) and the valve open up like an umbrella to
take the place of the diseased valve (Figure 1.1 : D). For the antegrade
approach, the prosthesis is inserted, also via a catheter, through the rib
cage and apex of the heart. This method is more invasive, however, it
allows for larger prostheses to be deployed.
These prostheses are still in the medical trial phases and there are
not yet any products available commercially. There are many reported
difficulties associated with this type of valve [11; 12; 13]. These issues
include difficulty in sealing the valves to prevent regurgitation; achieving
a low profile, i.e. achieving a small device that is easy to navigate to
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the desired position; deterioration of the leaflets and a limited life span;
coronary obstruction and difficulty in achieving exact positioning of the
valve. Additionally, there are very little published literature available
regarding the development of these valves. This may be attributed to the
fact that the development companies are very resolute to protect their
intellectual property.
1.3 Research Objective
The Biomedical Engineering Research Group in collaboration with the
Cardiology Department of the University of Stellenbosch have initiated
a project to develop a percutaneous aortic heart valve that addresses the
difficulties listed in Section 1.2. The project was sub-divided into three
MScEng projects, each project focusing on a different aspect of the re-
search project. The projects focused respectively on the valve leaflet de-
sign [5] and an analysis of the hemodynamic valve characteristics [4].
The present work relates to the structural development and analy-
sis of the stent component for the valve prosthesis. Since many of the
difficulties associated with these valves are directly related to the perfor-
mance of the stent component, and since its performance plays a major
role in the successful and efficient functioning of the prosthesis, the main
objective of the study is to successfully develop and test a prototype stent
component that addresses and solves these difficulties. Since a vital step
in the product development cycle is the successful completion of the an-
imal trial phase, the work will focus on developing a prototype that will
be suitable for implantation in sheep (animal trial phase). Upon success-
ful completion of the animal trial phase, the developed prototype may
be scaled to human dimensions. The outcome of this thesis will provide
a better understanding of the aspects that determine successful develop-
ment of a stent for implementation in a percutaneous aortic heart valve.
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1.4 Research Methodology
In order to achieve the objective as stated in Section 1.3 a thorough un-
derstanding of the field of stenting technology, the field of minimally
invasive cardiac intervention and related fields is required. For this rea-
son, a thorough literature review was conducted of the abovementioned
fields, the results of which are presented in this thesis report. From the
literature review as well as brain-storming sessions held with the devel-
opment team, a list of engineering requirements for the stent component
were identified. From these requirements a number of concepts for the
stent component were developed.
The stent component of a percutaneous aortic valve prosthesis is an
intricate device, involving complex geometries as well as several defor-
mation modes. Due to the time and high cost involved in stent prototype
manufacturing and testing, there existed a need for a low-cost approach
to generate the required stress and deformation data to support the de-
sign of the device. This would aid in a better understanding of the me-
chanical characteristics of the device as well as minimise the number of
design iterations required.
It was therefore decided to implement the finite elementmethod (FEM)
to analyse the forces and deformation modes that characterise the per-
formance of the stent. The finite element (FE) package, MSC.Marc was
selected to perform the analyses as it was capable of solving non-linear
problems, it was compatible with the pre-processor packageMSC.Patran,
and both of these packages were availible at the University of Stellen-
bosch.
The generated concepts were first subjected to simplified finite ele-
ment analyses (FEA) to identify the most promising concepts. From this,
the two most promising concepts were identified and a complete struc-
tural finite element analysis was conducted for the stents in order to de-
termine the structural characteristics of the stent models. The structural
characteristics include aspects such as deployment pressure, dog-boning
and coning, elastic recoil, plastic deformation and strain, and minimal
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allowable crimping diameter. Elastic recoil refers to the elastic spring-
back of the stent after the deployment pressure has been removed. The
term "recoil" is preferred over "spring-back" as it is the generally accepted
term used for stent design applications. Detailed definitions of these as-
pects are given in the text. From the results of the finite element analyses
a strut width was selected for each stent component and ten prototypes
were manufactured for each of the concepts. Tests were conducted on the
prototypes to analyse the prototype performance as well as in an attempt
to validate the numerical results of the finite element analyses.
From the results of the FEA as well as the experimental analyses,
the advantages and disadvantages of each concept were identified and
the concept most suitable for the application was identified. Limitations
to the research conducted were identified and recommendations were
made towards future work.
Chapter 2
Literature Review
2.1 Introduction
Successful development of a stent for the application in the percutaneous
replacement of an aortic valve requires a thorough understanding of the
design parameters and environment variables that determine the perfor-
mance of the stent. It is also important to be acquainted with the scope
and results of past research in the field as well as related fields and to
identify the methods implemented to conduct the research. This enables
the researcher to establish a new perspective into the field, to determine
the shortcomings of the current research and to determine the context
of the proposed research project. For these reasons, a thorough litera-
ture review was conducted into the field of percutaneous aortic valve re-
placement and related fields. The knowledge gained from the literature
review is presented here.
The literature review discusses the results of recent animal and hu-
man trials, parameters that influence stent performance, current method-
ologies applied in the research, the challenges faced in current research as
well as limitations of the current research. The context for the proposed
research project is also established and finally, conclusions are drawn
from the knowledge gained in the literature review.
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2.2 Previous Medical Trials
2.2.1 Animal Trials
The first report of a successful percutaneous implantation of an aortic
valve into an animal test subject was published in 1992 [12; 14]. In this
study, stented valves were deployed successfully in seven pigs, however
three of the pigs experienced complications associated with restriction of
the coronary blood flow. The results of this study highlighted the impor-
tance of correct positioning of the prosthesis as well as taking coronary
perfusion into account.
A number of animal studies have since been conducted [11; 12; 15].
These studies again brought to light the importance of designing the
prosthesis to allow for coronary perfusion, employing a feasible position-
ing and alignment strategy and ensuring minimal prosthesis migration.
The results of a study conducted by Boudjemline and Bonhoeffer [16]
on a group of lambs indicated that the percutaneous implantation of
prosthetic aortic valves that are hemodynamically unnecessary and in
which the native valves do not experience a minimal amount of back
flow, will become covered in neointimal tissue, eventually rendering them
incompetent. It is therefore a requirement that, for each animal used in
a trial phase following prototype development, an aortic insufficiency
must be established prior to the deployment of the valve. This may be
done by means of aortic angioplasty [16] or a similar technique.
2.2.2 Human Trials
The first human implantation of a stented aortic valve was reported in
December 2002 [17]. A short stent (14 mm) was used to minimize the risk
of coronary obstruction while allowing deployment of the valved stent in
the native position. The deployed stented valve functioned normally and
no coronary obstruction occurred. The success of this procedure proved
that with the use of a short stent and with the proper positioning of the
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prosthesis it is possible to avoid coronary obstruction and interference
with the mitral valve.
By 2005, Bonhoeffer had already implanted 81 valves in 75 patients
with a 98% success rate [18]. CoreValve, a company who is currently
developing a self expanding valve, has recently received approval for a
European clinical trial involving 20 patients [19].
2.3 Desired Stent Attributes
According to a paper published by Poncin and Proft [20], the perfor-
mance characteristics of a stent are directly related to the mechanical and
physical properties of the material used to produce the stent. These per-
formance characteristics include biocompatibility, X-ray and MRI visi-
bility, radial strength, elastic recoil, flexibility, deliverability, profile, and
long term integrity.
For an aortic valve stent a high radial strength is required to with-
stand the external compressive forces, imposed by the native aortic tis-
sue, as well as the valve leaflet forces. recoil must be limited to a min-
imum to ensure the efficient anchoring of the device. Foreshortening
must be restricted to a minimum en ensure the minimal deformation of
the valve leaflets. The stent must exhibit a low profile to ensure the easy
deliverability of the device and resistance to fatigue is important due to
the cyclic forces imposed by the valve leaflets.
It is also known that a stent’s geometric features have a major influ-
ence on the performance of a stent. It is therefore of interest to research
the characteristics of the materials that are commonly used in stent appli-
cations and to analyze the performance impact of the various geometric
properties of a stent.
2.3.1 Ideal material properties
The ideal properties of the material used to produce a stent are corro-
sion resistance, vascular compatibility, fatigue resistance and visibility
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using standard X-ray and MRI equipment [20]. For balloon-expandable
stents, a high elastic modulus will minimize recoil. A low yield strength
is preferred to ensure that the balloon pressure required to produce the
desired stent expansion is low enough (below five bar) to allow for man-
ual pressurisation. A low yield strength is also required to enable effec-
tive stent crimping. High tensile properties will enable the volume of
implanted material to be minimized while still achieving the required
radial strength. This also allows the use of thinner struts to achieve an
overall lower profile, improving flexibility and deliverability. A steep
work-hardening rate provides the required rise in strength during ex-
pansion. A high ductility is advantageous as it is required to endure the
deformation during expansion.
Some of the properties mentioned in the previous paragraph are re-
lated to each other in a conflicting manner. For this reason it is vital to de-
termine the most significant material properties and accordingly achieve
a cautious compromise between the materials available, in which some
properties may be sacrificed for others.
2.3.2 Ideal tubing properties
Given that metal tubing is the most commonly used profile to produce
stents, it is important to investigate how the tubing attributes influence
the stent performance and manufacturability.
Typically, two distinct methods exist to produce tubing. These meth-
ods include welded-redrawn or seamless form. Despite modern welding
techniques and advanced inspection systems, it is not possible to fully
eliminate defects from the weld without localized micro-contamination
and segregation [20]. Therefore it is preferable to utilize seamless tubing
for stent applications.
The material properties of some materials are very sensitive to the
tube drawing process. For this reason, a fine degree of control is re-
quired during the process to ensure repeatable properties for the tubing.
The sensitivity however, provides the possibility to tailor the material
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properties according to the requirements of the prosthesis. Tailoring of
the material properties is only possible if the manufacturer has a sound
knowledge of the detailed material behavior and tightly controls the pro-
cess.
Materials with uniform and equally-axed small grain microstructures
are generally preferred for polishing as well as resistance to fatigue and
corrosion [21]. Minimizing the grain size will typically raise the yield
strength with unfavorable consequences on recoil at crimping and ex-
pansion [20]. This is an example of properties that are related in a con-
flicting manner and, consequently, a compromise must be reached that
will be best suited for the specific application.
Dimensional accuracy is also critical to stent performance and man-
ufacturability [20]. A consistent wall thickness is required to achieve an
even deployment of the stent. The majority of commercially availible
stents are manufactured using a laser cutting process. It is of utmost
importance to achieve a consistent strut width during the laser cutting
process, which can only be achieved if the tubing has a consistent wall
thickness. The outside diameter determines the accuracy of the guidance
of the tube under the laser beam. For this reason, fine tolerances and
tight cylindricity on the tubing is required.
The surface finish of the tubing is also an important factor to consider
and must be smooth enough such that the cleaning and electropolishing
procedures can achieve the desired stent finish.
Dimensional accuracy and surface finish are greatly influenced by the
type of tube drawing process used. The floating and fixed plug drawing
process produces the best geometry and surface finish [20]. However,
this process is only possible if it is compatible with the selected mate-
rial, required dimensions and the desired temper. An alternative process
is the ductile core drawing technique. However, this process does not
usually provide the same degree of accuracy achieved with hard tool
techniques [20].
Although a fully annealed condition is preferred for the final stent,
cold worked tubing is often used during the laser cutting process, fol-
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lowed later by an annealing process. The subsequent annealing process
should be adequately controlled to achieve the desired mechanical prop-
erties and microstructure. This approach minimizes the possibility of
handling damage and relieves residual stresses imposed by the laser cut-
ting process.
2.3.3 Influence of the geometric properties of a stent
It is known that stent design plays an important role in the restenosis rate
of arteries and also the radial strength of the stent [22]. The strut thick-
ness has also been linked to the endothelialization of the stent surface
after implantation.
The sharp edges of the stent should be rounded to reduce the stress
concentrations at the joints and to prevent the stent from cutting into the
artery walls [22].
2.4 Modeling of Stent Behavior using FEM
A number of papers have been published on the finite element models
constructed to perform non-linear simulations of stent behavior during
crimping, expansion and stent-artery contact interaction. These simula-
tions aim to accurately predict the time-dependant stresses and strains
present during these processes. Application of finite element studies in
this respect allows impact of various stent parameters to be analyzed
without physically producing the stent or performing physical experi-
ments. The impact of geometric design parameters on important stent
performance characteristics such as radial recoil, foreshortening, stress
concentrations and deployment pressure could be analyzed. The ge-
ometric design parameters include strut geometry, strut thickness and
material selection to name but a few.
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2.4.1 Strategies employed in finite element simulations
Due to the complexities involved in the processes that take place during
the percutaneous implantation of a stented aortic valve, accurate simula-
tion of these processes is a challenging task. For this reason, innovative
methods must be implemented to simulate these processes in a simplis-
tic manner, while maintaining the reliability of the results. The strategies
employed to achieve this is described in this section.
2.4.1.1 Strategies employed to generate stent models
Published literature indicates that solid brick elements (C3D8), wedge
elements (C3D6) and tetrahedral elements (C3D4) are commonly imple-
mented in stent models [22].
For the finite element simulations, it is vital to ensure that the mesh of
the model is sensitive enough, to ensure that the solution will converge
to the correct answer [22]. However, a very fine mesh will result in an in-
crease in the analysis time. For this reason, all possible measures should
be taken to ensure that the solution converges, while limiting the analysis
time to a minimum.
The balloons used to deploy the stents are often modeled as expand-
able cylindrical tubes [2]. The material type of the tubes is selected as
polyurethane with equal material toughness and a bi-linear hyper-elastic
(Mooney-Rivlin) model is implemented to represent the stress-strain be-
havior. The specific material properties for these materials are available
in the literature [2].
2.4.1.2 Strategies employed to simulate the stent loading conditions
Due to the axial symmetry that is present in most stent geometries, it is
often possible to use only the repeated symmetrical segment to simulate
the deformation processes [2]. In these cases, it is very important to im-
plement the correct boundary conditions on the nodes of the stent which
are located in the plane of symmetry.
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Figure 2.1: Pressure Load Functions [2]
The pressure loads are often simulated as a uniform surface load on
the inner surface of the balloons (which are represented with cylindrical
tubes) [2]. A three stage continuous linear function is used to represent
this surface load. A ramp-up function is used to achieve the inflation of
the balloon. A constant function is used to represent the expanded state
of the balloon and a ramp-down function is used to achieve the deflation
of the balloon. In such a case, the time duration of each stage is not very
important, as a quasi-static solution is desired. It is however important
to allow enough time for each stage to ensure that the solution converge
to the equilibrium status. This approach ensures that the dynamic effects
are limited to a minimum. Figure 2.1 shows a diagram of typical load
functions used to simulate the pressure load.
When different stent geometries are compared to each other, it is re-
quired that the different geometries are compared in an impartial man-
ner. To achieve this, the stents are expanded to a certain limit, for exam-
ple a certain percentage of its failure strength, and the resulting stresses
are analyzed and compared to each other.
2.4.1.3 Strategies employed in static deformation simulations
Experimental studies indicate that stent design have a significant impact
on the long term clinical outcomes of patients undergoing coronary stent
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placement [23; 24]. For this reason, it can be assumed that stent design
will also have a major impact on the performance of percutaneous aortic
heart valves. Since the crimping and expansion processes of the stent
involve large deformations, the non-linearities of the stentmaterialsmust
be carefully considered.
Results from static deformation simulations
Results of static deformation simulations found in the literature indicate
that an increase in the number of struts in the circumferential direction of
a stent results in more material available for expansion and subsequently
produces a beneficial effect on the expansion in the radial direction [2].
However, an increase in the number of slots in the circumferential direc-
tion of the stent results in an increase in the elastic recoil.
The results also indicated that an increase in the strut width results in
an improvement in the resistance against excessive elastic recoil as well
as an increase in the resistance against compressive forces applied by
the vascular wall after deployment. However, an increase in strut width
will also increases the difficulty with which a stent expands during the
inflation process and limits the flexibility of the stent. It is important to
establish a balance between radial strength and flexibility of the stent.
A decrease in the crimp radius of a coronary stent results in an in-
crease in the equivalent plastic strain [22]. This is of particular interest in
the current project as a valve stent could possibly undergo large crimp-
ing deformations. The maximum Von Mises stress in the stent after ex-
pansion increases with an increase in the accumulated plastic strain [22].
Again, this is of particular interest in the current project as the valved
stent may experience large accumulated plastic strain. If the maximum
stress levels approach the ultimate stress for the material, this may be-
come a problem.
The radial strength of the stent increases with accumulated plastic
strain [22]. This means that the stent is stronger and that it is able to with-
stand more pressure from the arterial walls. Accordingly a stent which is
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fabricated at a greater diameter and then crimped to its minimum diam-
eter will have an increased radial strength.
Effect of deployed diameter
The radial force required to expand a stent increases as the deployment
diameter increases [22], which means that there will be an increase in
the stress levels. However, the radial recoil decreases with an increase in
deployment diameter.
2.5 Fatigue-life Simulations
The stent implemented in a stented heart valve will be subjected to cyclic
blood pressures as the heart beats, as well as the cyclic forces from the
valve leaflets. For this reason, a cyclic fatigue loading analysis of the
stent is particularly important. Failure resulting from the cyclic forces
is an event that could threaten the life of a patient. The frequency of the
cyclic forces will be approximately 60 cycles a minute or 31 million cycles
a year. If the stent is to have a life of at least ten years, it must be designed
to withstand in excess of 310 million loading cycles.
In a recent paper on the fatigue and life prediction of cobalt-chromium
stents, a new method is proposed to quantitatively predict the probabil-
ity of fatigue failure of a stent [25]. This approach combines both a tradi-
tional stress-life (S-N) predictive methodology and a fracture mechanics
analysis to conservatively evaluate the design life of the stent. The new
approach enables the deduction of a safety factor to failure from the sim-
ulation data, whereas this safety factor remained unknown in previous
methods. The stress-life predictive methodology is of particular inter-
est to this study, however the fracture mechanics analysis is beyond the
scope of the present work.
In [25], the processes during stent deployment, namely crimping, balloon-
inflation and recoil were first simulated to establish the residual stresses
that would be present in the stent after deployment. Thereafter, max-
imum and minimum pressure loads were then sequentially applied to
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the internal surface of the stent to represent the physiological systolic
and diastolic blood pressure as a result of the cardiac cycle. The max-
imum principal stress distribution across the stent for the two pressure
loads was subsequently used to calculate a fatigue safety factor (FSF), as
described below.
The mean stress and stress amplitude distributions were calculated
from the predicted maximum principle stresses across the stent. From
these values a modified-Goodman relationship was used to determine
a FSF distribution, which basically quantifies the proximity of the mean
stress and stress amplitude at any given point to the Goodman curve.
The element with the lowest safety factor was then identified as the loca-
tion most susceptible to fatigue failure.
As the stent that will be developed in the proposed project will be
subjected to not only cyclic pressure loads from the cardiac cycle, but
also cyclic loads from the valve leaflets, an assessment of the effect of
mixed-mode loading would be required.
2.6 Challenges
Due to the unique anatomy of the aortic valve, the percutaneous replace-
ment of this valve presents several distinctive challenges. As the aortic
valve lies in close proximity to both the mitral valve and coronary ar-
teries, the correct positioning of the valve is extremely critical. If the
valve is to be placed in the native position, inaccurate placement of the
valve in either direction could result in severe acute mitral dysfunction
or severe acute ischemia. For this reason, alternate strategies towards the
positioning of the valve relative to the native position must be carefully
considered.
Another challenge posed by percutaneous valve replacement meth-
ods is to ensure the stable positioning of the stent in order to prevent
migration or embolization, despite high systemic pressures. There also
exists a risk of peri-procedural embolization and this aspect must be ad-
dressed as well.
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Delivery of the prosthesis to the correct position poses a number of
difficulties and there are currently two different methods towards the
delivery of the prosthesis that are being studied. Both an antegrade and
retrograde approach exists towards the delivery of the prosthesis, each
with its own advantages and limitations. The transseptal antegrade ap-
proach would allow easier passage of large-profile valved stents as well
as more precise placement of the prosthesis. However, this approach
would entail passage through (and possible damage to) the native mitral
valve. The retrograde approach would enable the delivery of the pros-
thesis without the need for transseptal puncture and would eliminate the
risk of damage to the native mitral valve. However, if surgical vascular
access and repair is to be avoided, this approach would require a low-
profile system.
2.7 Shortcomings
Although a number of papers have been published on the simulation of
the processes involved in the implantation of arterial stents, no papers
have been found on the simulation of aortic valve stents. For this reason,
there is currently no public knowledge available on the forces that these
devices are subjected to.
Since percutaneous aortic valve replacement methods have only re-
cently come into practice (past 15 years), there are no published litera-
ture on the long-term durability of the valved stent and the risk of late
migration or embolization. The valve leaflet material currently used in
stented valves are not particularly resistant to corrosion and have a very
limited life-span.
Considerable energy is being invested to develop materials in order
to enable the effective use of MRI imagery, which is characterized by the
ability to display tissue contrast, an absence of radiation and the ability
to determine the blood flow within the stent.
Several companies are currently conducting research in the field of
percutaneous aortic valve replacement, including NuMed Inc. and Pal-
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maz/Bailey. Core Valve is also developing a percutaneously delivered
aortic valve system that utilizes a self-expanding stent. Edwards Life-
Sciences also researches the development of stented valves and has re-
ceived FDA (Food and Drug Administration) approval to initiate a clin-
ical trial in patients considered high risk for conventional open-heart
valve surgery [26].
2.8 Summary of Knowledge Gained
The following paragraphs provide a summary of the most important
knowledge that was gained through the literature review with respect
to stent design.
The structural design of the stent is very important with respect to
coronary perfusion and the positioning strategy. A short stent is prefer-
able.
The material used to produce a stent must be corrosion resistant, bio-
compatible and have a high resistance against fatigue. A high elastic
modulus and low yield strength is preferable. High tensile properties are
required to minimise the profile of the device. A steep work-hardening
rate and high ductility is also advantageous.
Seamless tubing is the preferredmaterial for stent applications. Mate-
rials with uniform and equally-axed small grain microstructures are pre-
ferred with respect to polishing and resistance to fatigue. Metal tubing
with extremely tight tolerances are required to ensure an accurate manu-
facturing process. A smooth surface finish is required to achieve optimal
results from the electropolishing process.
The finite element method provides an excellent tool to evaluate stent
design parameters, while eliminating the high cost of physically man-
ufacturing many design iterations. A sufficiently sensitive mesh is re-
quired to ensure convergence of the solution. For most stent geometries,
symmetry models may be used to reduce the analysis time of finite ele-
ment simulations. The internal pressure load on the stent may be simu-
lated using a three stage continuous linear function.
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With respect to stent geometric design, an increase in the number of
struts in the circumferential direction has a beneficial effect on radial ex-
pansion. An increase in the number of slots in the circumferential di-
rection results in an increase in radial recoil. An increase in strut width
provides resistance against excessive elastic recoil as well as an increase
in resistance against external compressive forces. However, stent expan-
sion and flexibility are compromised by an increase in strut width.
Fatigue failure is an aspect that should be very carefully addressed
during the process of stent design. For this thesis the effect of mixed
mode loading on the fatigue life of the stent must be considered.
Delivery and stable stent positioning are challenges which remain
largely unsolved and should be addressed during the prosthesis devel-
opment cycle. A low crimped profile is very important with respect to
developing a simple delivery technique.
The knowledge gained in the literature review will serve as a guide-
line to specify the desired tubing characteristics as well as provide a basis
to develop novel strategies towards the geometric design of the stent.
Chapter 3
Stent Design Requirements
3.1 Performance Requirements
A study of the published literature, weekly brain-storming sessions as
well as correspondence with Dr. H. Weich, a cardiologist at Tygerberg
Hospital, led to the formulation of the performance requirements for the
stent. Although an international standard for percutaneous aortic valves
does not yet exist, the ISO 5840 International Standard for Cardiac Valve
Prostheses [27] was also used as a guideline to formulate the stent design
requirements. The identified requirements as well as their accompany-
ing motivations are listed in table 3.1. Along with the motivation, the
source of each design requirement (where applicable) is also provided as
a reference.
3.2 Material Requirements and Selection
As mentioned in the literature review, the material requirements for a
stent used in an aortic valve are corrosion resistance, vascular compat-
ibility, high radial strength, fatigue resistance and visibility using stan-
dard X-ray and MRI equipment [20].
There are two distinct material types commonly used for the man-
ufacturing of stents. These include shape-memory alloys and fully an-
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Table 3.1: Geometric Design Requirements for the Stent
Design Requirement Motivation
a) Deployed diameter: 20 mm Average diameter of a sheep’s
aortic annulus [10]
b) Maximum length: 16 mm Minimise profile to avoid coro-
nary obstruction [10]
c) Crimping diameter: 18 French (6
mm)
Minimise crimping diameter to
allow femoral arterial access [10]
d) MaximumDeployment Pressure: 5
Bar
Maximum realistic deployment
pressure for manual pressurisa-
tion [10]
e) Minimum Load Cycles: 156 Mil-
lion
Load cycles required for a 5-year
life-span [27]
nealed bio-metals [20]. Shape memory alloys, such as nitinol, are used to
manufacture self-expanding stents whereas bio-metals, such as titanium
and cobalt-chrome, are used to manufacture balloon-expandable stents.
Self-expanding stents manufactured from shape-memory alloys have
the advantage of a low profile (small minimum crimping diameter), due
to the absence of the balloon. The expansion-process of self-expanding
stents can also be very well controlled, which is a great advantage for the
positioning and deployment process. However, shape-memory alloys
are very difficult to machine and handle. Therefore a keen knowledge of
the material characteristics and manufacturing experience are required
to manipulate them. Another disadvantage of there materials are their
limited radial strength. These materials are also fairly expensive.
Bio-metals commonly used in the manufacturing of balloon expand-
able stents normally have high elastic modules, high tensile properties,
a steep work hardening rate and high ductility. As a result of these fac-
tors, balloon-expandable stents have high radial strengths and in addi-
tion to this, these stents are easy to manufacture and handle. However,
the literature indicates that balloon expandable aortic valves are difficult
to position and deploy.
In light of the discussion above, it was decided to use a bio-metal to
manufacture the stents for this project. The primary motivation for this
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selection was the lack of experience working with shape-memory allows,
the easy processing and handling of bio-metals as well as the favourable
mechanical properties of bio-metals.
With respect to bio-metals, two materials were identified to exhibit
properties that are favourable for the manufacturing of the stent proto-
types. These materials include Stainless Steel (SS) 316L and the Cobalt-
Chrome family of alloys. These two metals have similar mechanical
properties, however the cobalt-based alloys exhibit comparatively higher
densities, elastic moduli, strengths and differences between yield and
ultimate tensile strengths [20]. Although stainless steel is currently the
workhorse material used for balloon expandable stents, cobalt-chrome,
and specifically CoCr L605 and CoCr MP35N, exhibit slightly superior
properties and is becoming more and more popular as materials used in
stent manufacturing.
However, cobalt-chrome tubing in the required dimensions is not read-
ily available in South Africa, and on top of this, it is very expensive. As
a result of the scarcity and high cost of cobalt-chrome tubing, it was de-
cided that annealed SS 316L would be used to manufacture the stents for
this project. Medical grade seamless SS 316L tubing in the required di-
mensions is also relatively expensive and not readily available. Therefore
non-medical grade seam-welded SS 316L was selected as the material for
the prototypes. The effects of aspects such as material impurities and
tubing concentricity were unknown and would be highlighted by this
project. Approximately two meters of tubing with an outer diameter of
9.5 mm and a wall thickness of 0.5 mm were acquired as an off-the-shelf
product from a supplier located in the United Kingdom. Ideally, it would
be desirable tomanufacture the stents to the deployed diameter, however
the available laser cutter of Disa Vascular (Pty) Ltd. could only cut to a
maximum outer diameter of 10 mm.
In order to verify the mechanical properties of the acquired material,
an uni-axial tensile test was conducted on a sample of the material us-
ing a 250 kN Amsler machine. The test data was electronically recorded
using a SPIDERTM bridge amplifier / data acquisition system and the
CHAPTER 3. STENT DESIGN REQUIREMENTS 24
 
   
   
   
   
   
   
   
                          




	







Figure 3.1: SS 316L: Tensile Test
Table 3.2: Mechanical Properties of SS316L
Literature Data Experimental Data
Elastic Modulus (E) 193 GPa 187 GPa
Yield Strength 340 MPa 334 MPa
Tensile Strength 670 MPa 619 MPa
results are given in Figure 3.1.
The elasticmodulus, yield strength (0.2%) and ultimate tensile strength
for the data found in the literature as well as the experimental data are
given in Table 3.2.
Since the experimental data corrolated well with the data found in the
literature, it was determined that the experimental data would be used
in the finite element analyses. The material properties that were deter-
mined from the axial test were also used for the circumferencial direction
(isotropic material model). This was done because the material was used
in the annealed state and it was therefore assumed that the properties in
the axial and circumferencial direction would be similar.
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Figure 3.2: Parabolic Assembly Figure 3.3: Straight Assembly
3.3 Stent-Leaflet Interface Requirements
Mr. A. Smuts, a co-member of the valve development project, deter-
mined in his thesis report on the "Design of Tissue Leaflets for a Percuta-
neous Aortic Heart Valve" , that there are two feasible configurations for
the shape and the assembly of the valve leaflets to the stent frame [5].
For the first configuration, indicated in Figure 3.2, the valve leaflets are
sutured to the stent frame in a parabolic fashion. The line of suturing
is indicated by the red dots. This assembly configuration has the ad-
vantage that the shape of the valve leaflets represents the profile of the
native aortic valve. According to Chikwe et al. [28] this is an important
characteristic of an effective replacement valve.
For the second configuration, indicated in Figure 3.3, the valve leaflets
have a square form, and the sides of the leaflets are sutured to the stent
frame along a straight line. Again, the line of suturing is indicated by the
red dots. The advantage of this assembly configuration is the inherent
ease of assembly [5].
It was a vital requirement of the stent frame to be compatible with
either the parabolic assembly configuration or the straight assembly con-
figuration. For this reason, the stent frame had to have a strut pattern
which was orientated in such a manner to allow for the suturing of the
valve leaflets along the line of suturing (red dots in the figures).
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Table 3.3: Stent Deformation Requirements
Deformation Process Initial Diameter Final Diameter
(mm) (mm)
a) Assembly Expansion 9.5 20
b) Crimping Process 20 6
c) Deployment Process 6 20
3.4 Stent Deformation Requirements
It is inevitable that any stent implemented in a percutaneous aortic heart
valve would be subjected to a number of deformation processes prior to
the final deployment step. As mentioned in Section 3.2, prototype stents
for this project would be laser cut from tubing with an outer diameter of
9.5 mm. The stent would therefore be subjected to an initial expansion
process, to allow for the valve assembly. The expansion process would
be followed by the crimping of the stent on to the balloon catheter. The
crimping process, in turn, would be followed by the final deployment
process, once the balloon is in position. Details of the required defor-
mation processes are given in Table 3.3. The required changes in diame-
ter during the assembly, crimping and deployment processes were con-
strained by the design requirements for the stent (refer to Table 3.1).
It was therefore a requirement of the stent that it should be capable of
enduring the deformations as described in Table 3.3 without exceeding
the material’s stress or strain limits.
Chapter 4
Concept Development
4.1 Concept Development Methodology
Since there are no fixed formulas or equations that can be used to de-
termine the required geometry of a stent, the development of a stent re-
quires an iterative concept development phase.
Accordingly, a review of the literature aswell as weekly brain-storming
sessions aided in the generation of a number of conceptual models, tak-
ing into account the design requirements as stated in Chapter 3. Since a
complete finite element analysis, to determine all the deformation and
performance characteristics of each developed concept, would be ex-
tremely time consuming, it was determined that an initial concept eval-
uation phase would be conducted in which each of the concepts would
be subjected to a simplified finite element analysis of the three main de-
formation processes. The initial finite element analyses are refered to as
"simplified" as rigid cylinders were used to achieve all of the deformation
processes and the stent characteristics such as foreshortening and recoil
were not analysed. From these analyses the most promising concepts
were selected for an in-depth analysis and concept refinement phase.
For the initial concept evaluation phase, each of the developed con-
cepts were subjected to the initial expansion process, the crimping pro-
cess and the deployment process by implementing rigid expansion and
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Figure 4.1: FEM Diagram for Concept Simulations
crimping cylinders. An in-depth discussion of the methods and tech-
niques applied to perform the finite element analyses are provided in
Chapter 5. Figure 4.1 shows a diagram which depicts the initial expan-
sion (c), crimping (e) and deployment (f) process that was simulated for
each concept. For each concept, the stent was first expanded to a diame-
ter of 20 mm, after which the stent was crimped to a diameter of 6 mm.
Finally, the stent was again deployed to a diameter of 20 mm.
The concepts which were rejected due to a non-compliance with one
or more of the requirements are described in Appendix A.
4.2 Final Conceptual Models
From the initial concept evaluation phase it was concluded that two of
the concepts were feasible according to the generated design require-
ments. These concepts were selected for an in-depth finite element anal-
ysis and futher refinement. Figures 4.2 and 4.3 shows the CAD models
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Figure 4.2: Stent Concept A Figure 4.3: Stent Concept B
Figure 4.4: Stent Concept A - Wireframe
of the selected concepts as well as the interfaces with the tissue leaflets.
4.2.1 Description of Concept A
Concept A consists of multiple rows of zig-zag shaped struts. The rows
are interconnected to each other via conncetions between the apexes and
bases of each row of struts. This configuration results in the formation
of diamond shaped cells when the stent is deformed into the deployed
state (Figure 4.2). This concept is compatible with the parabolic assembly
configuration (Section 3.3). Figure 4.4 shows an unfolded wireframe of
Concept A. With reference to this text, the distal and central sections of
the concept are also indicated in the figure.
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Figure 4.5: Stent Concept B - Wireframe
4.2.2 Description of Concept B
Concept B consists of three support props, which serve as assembly joints
for the three leaflets of the valve. The support props are connected with
four rows of zig-zag shaped struts, which are translated in the axial di-
rection. This configuration is compatible with the straight assembly con-
figuration (Section 3.3).
Figure 4.5 shows an unfolded wireframe of Concept B. The distal and
proximal sections of the concept are also indicated in the figure. This de-
sign is similar to the design of the stent used in the Edwards SAPIEN
Transcatheter Heart Valve from Edwards Life Sciences [29], however,
there are some critical differences. The support props extend well be-
yond the end of the struts, whereas, the Edwards design has support
props which end in line with the struts. This feature was implemented
to allow for the straight assembly configuration, while minimising the
possibility of coronary obstruction. The rows of the zig-zag strut pattern
are uni-directional (they face in the same direction), whereas the zig-zag
strut pattern of the Edwards valve are mirrored around the midplane of
the stent. The uni-directional strut configuration helps to minimise the
cyclic stresses to which the extended support props would be subjected
(Section 5.8). This may be attributed to the fact that the top row of struts
are connected with their top end to the support props, as opposed to
the support props extending to the bottom ends of the top row of struts,
which is the case with the Edwards design.
Chapter 5
Numerical Simulations
5.1 Introduction
Although the two most promising stent concepts were identified as de-
scribed in Section 4.2, the exact geometric dimensions that would bemost
suited for the specific stent application had to be determined. For this
reason an in-depth FEA was conducted for each concept to determine
the influence of strut width on the stent characteristics such as stress and
strain, recoil, foreshortening, fatigue-life, etc. To eliminate possible ambi-
guity between strut width and strut thickness, Figure 5.1 shows a section
of Concept A for which the strut width is indicated. Strut thickness is
determined by the wall thickness of the tubing used to manufacture the
stent.
For Concept A, the analyses were conducted for strut widths of 0.20
mm, 0.23 mm, 0.25 mm and 0.27 mm. For Concept B, the analyses were
conducted for strut widths of 0.20 mm, 0.22 mm, 0.25 mm and 0.27 mm.
Figure 5.1: Strut Width
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Table 5.1: Concept A: Geometric Parameters
Category Strut Width
.20 mm .23 mm .25 mm .27 mm
Metal surface area (mm2) 128.559 137.354 141.115 143.877
Stent surface area (mm2) 562.427 569.163 572.276 575.862
Metal-Surface area ratio 0.229 0.241 0.247 0.250
Undeformed length (mm) 18.845 19.071 19.175 19.295
Deployed length (mm) 17.499 17.635 17.729 17.941
There is no scientific reason for the discrepency between a strut width
of 0.23mmused for Concept A, and 0.22mmused for Concept B, whereas
the other width values are the same. This was due to a technical error
made during the CAD modelling of Concept B, which was discovered
at a stage which was too late to remodel, simulate and process the re-
sults for a strut width of 0.23 mm. Since the data for a strut width of 0.22
mm was still usefull to provide insight into the stent behaviour, it was
included in the thesis.
For both concepts, the geometric parameters for the various strut widths
are given in Tables 5.1 and 5.2. With respect to the tables, "metal surface
area" refers to the outer surface area of the stent, whereas "stent surface
area" refers to the arterial surface area covered by the stent (stent circum-
ference × stent length). The geometric parameters for the concepts were
determined from the generated CAD models. From the numerical anal-
yses a strut width could be selected for each concept that would be most
suited for the application. The results of the analyses are reported in this
chapter.
5.2 Analysis of Stent Loading Conditions
Prior to performing a finite element analysis of the stent loading and de-
formation conditions, the processes involved during the assembly, de-
ployment and operation of a percutaneous aortic heart valve need to be
addressed.
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Table 5.2: Concept B: Geometric Parameters
Category Strut Width
.20 mm .22 mm .25 mm .27 mm
Metal surface area (mm2) 150.384 159.235 172.838 182.000
Stent surface area (mm2) 515.574 516.171 517.066 517.663
Metal-Surface area ratio 0.292 0.308 0.334 0.352
Undeformed length (mm) 20.5 20.5 20.5 20.5
Deployed length (mm) 20.5 20.5 20.5 20.5
The stent is first mechanically expanded from the manufactured di-
ameter to the final deployed diameter in order to allow for the assem-
bly of the valve leaflets to the stent. The assembled prosthesis is then
loaded onto a balloon catheter. For this step, the stent is temporarily
crimped onto the inflatable balloon portion of the catheter, forming the
intra-vascular stent delivery system. Thereafter the delivery system is
percutaneously inserted into the femoral artery where it is translated
along the anatomical pathways leading to the position of the native aor-
tic valve (Figure 5.2). Once in the desired position, deployment of the
prosthesis is accomplished by the inflation of the balloon via hydraulic
pressurisation. This results in the expansion of the prosthesis into the
targeted site. During this step, the native aortic valve becomes trapped
between the stent and the wall of the aortic sinuses. Upon reaching the
desired deployment diameter, the balloon catheter is removed by defla-
tion of the balloon and subsequent extraction of the delivery system. The
final step of the deployment procedure occurs when the stent elastically
recoils to a slightly smaller diameter.
The deployment process is followed by the onset of a continuous
cyclic loading process which is induced by the cyclic leaflet forces as well
as the cyclic systolic and diastolic pressurisation. Both the cyclic leaflet
forces as well as the cyclic pressurisation is caused by the cardiac heart-
beats.
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Figure 5.2: Anatomical Vascular Pathways Leading to Native Aortic Valve [3]
5.3 Simulation Environment Setup
The FE simulation of the stent concepts presented a complex problem
as it involved severe non-linear behavior. The non-linear behavior in-
cluded geometric, contact and material non-linearities. The geometric
non-linearity was accounted for by activating the large stain/large dis-
placement algorithm and the material non-linearity was accounted for
by implementing a true stress - true strain elastic-plastic material model
with isotropic hardening. Contact boundary conditions were imposed to
manage the contact non-linearities (Section 5.5.2). In order to ensure that
the non-linear problem converged to an accurate state of equilibrium,
residual force and displacement tolerances of 1% were activated.
Adaptive time stepping was used along with the Full Newton Raph-
son iterative method to ensure that the iterative correction of the equi-
librium state could take place. A time-step scale of 1.5 was implemented
and the target iterations per increment was set to 15. AMulti-Frontal (Di-
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Figure 5.3: Concept B: FEMModel Setup
rect) Sparse solver was implemented to solve the equilibrium equations.
5.4 Finite Element Models of the Stent
Concepts
To set up the numerical models for the loading conditions as described
in Section 5.2, both stent concepts were first modeled as bi-parametric
surfaces using a CAD package. The surfaces were then imported into the
pre-processor MSC.Patran where they were first meshed using quadratic
surface elements. The surface elements were subsequently extruded to
eight-noded, isoparametric, three-dimensional brick elements with tri-
linear interpolation [30].
To simulate the "rigid" crimping and expansion of the stents, two
cylinders were created on either side of the stents using semi-rigid sur-
faces. Figure 5.3 shows the model setup that was used for the modeling
of Concept B. The model setup of Concept A was similar.
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5.5 Boundary Conditions
5.5.1 Displacement Constraints
Because of the cyclic symmetric forces imposed by the valve leaflets dur-
ing the fatigue loading step as well as the cyclic symmetry about the lon-
gitudinal axis present in both stent models, it was not necessary to model
the entire stent body, but rather only the segment of each stent that would
be subjected to the cyclically repeating forces. Since the valve leaflet
forces are tri-cyclically symmetric (each of the leaflets imposes forces on
the stent of the same magnitude and direction) it was only required to
model one third for both concepts.
For both concepts, the nodes in the planes of cyclic symmetry were
constrained to only allow for axial and radial translation in the symme-
try planes. For Concept A (Figure 4.2), axial constraints were imposed
on a single node in the plane of symmetry along the longitudinal axis
(center nodes) to prevent rigid body translation, ensuring that the model
was fully constrained within the simulated environment. The nodes at
either end of the stent was left unconstrained to allow for the extension
or shortening of the stent during the load steps. The imposed displace-
ment constraints for Concept A are indicated in Figure B.1 of Appendix
B. For Concept B (Figure 4.3), axial constraints were applied to a single
node at one end of the stent, while the other end was left free to extend
or shorten during the load steps. This was done to prevent the rigid
body translation of the stent, also ensuring that the model was fully con-
strained within the simulated environment. The imposed displacement
constraints for Concept B are indicated in Figure B.2 of Appendix B.
For both concepts, the maximum displacement of all the nodes were
constrained to simulate the displacement constraint imposed by the nom-
inal deployment diameter of the balloon. This implied that none of the
nodes could exceed the deployed diameter of 20 mm.
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5.5.2 Contact Constraints
For both stent models, rigid-deformable contact constraints were estab-
lished between the inner and outer surfaces of the stents and the semi-
rigid crimping and expansion cylinders. Self-contact were also activated
for the stent models. Elderly patients who qualify for a percutaneous aor-
tic valve replacement will most likely have aortic annuli and aortic valve
leaflets which are severely calcified. As a result of this, the geometry of
the calcified tissue may vary greatly between patients. On top of this,
the material properties of the calcified tissue are unknown and difficult
to determine. It is also likely that the calcified material would be fairly
brittle and have a limited contribution to the radial recoil of the stent. For
these reasons the interaction (contact) between the stent and the external
environment were not simulated for the purpose of this project.
5.6 Loadings Conditions
The loading conditions for the concepts were modeled as a number of
discrete steps in the sequence as they would occur during service. These
steps include (i) assembly expansion, (ii) crimping, (iii) balloon-deployment,
(iv) elastic recoil and (v) cyclic loading of the deployed stent. A represen-
tative of ESTEQ Engineering suggested that a solution time of one second
would be sufficient for each of the large deformation steps to allow for
convergence to the quasi-equilibrium state [31]. A solution time of 0.5
seconds was also deemed sufficient for the elastic recoil step. The solu-
tion time for each step is indicated in Table 5.3.
The initial assembly expansion stepwas simulated by applying a time-
field growth factor to the semi-rigid expansion cylinder. This implies that
the diameter of the expansion cylinder was controlled using a time de-
pendent table. Since a rigid-deformable contact constraint was active,
the stent expanded along with the expanding cylinder to the desired di-
ameter. After the expansion step, the crimping step was similarly accom-
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Table 5.3: Load Steps: Solution Time
Time
(sec)
Load Step
0 - 1 Assembly Expansion
1 - 2 Crimping
2 - 3 Balloon-Deployment
3 - 3.5 Elastic Recoil
3.5 - 4.5 Cyclic Loading
plished by applying a negative time-field growth factor to the semi-rigid
crimping cylinder.
The balloons used in stent applications are often modeled using a hy-
perelastic Mooney-Rivlin material model [32]. A hyperelastic material
is difficult to model since the material may experience a strain which is
several orders of magnitude higher compared to traditional materials,
which increases the structural instability of the elements [33]. In practice,
balloons used for stent applications are manufactured from polyester
polyethylene terephthalate (PET) materials which are non-compliant or
low-compliant [34]. This implies that the balloons retain their designed
shape even under high pressure. An attempt was made to model the
balloon according to the Mooney-Rivlin material model, however, it was
found that this model does not accurately describe the behavior of a PET
balloon.
Since an appropriate model could not be found or be generated to
model a PET balloon, it was decided to model the balloon-deployment
step by applying a uniform pressure to the internal surface of the stent.
The pressure was linearly increased until the stent reached the desired
deployed diameter. This approach had the limitation that the transfer of
outward vectored forces from the bulging balloon membrane to the stent
was not taken into account. Snapshots of some intermediate iterations of
the assembly, crimping and deployment load steps for Concept B can be
found in Appendix C.
After the deployment step, the stents were allowed to recoil by lin-
early decreasing the internal surface pressure. This load step represented
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Table 5.4: Concept A: Mesh Convergence Analysis
# Nodes # Elements Deployed Diameter
(mm)
5640 1880 19.92
26050 13760 16.9
61200 37850 17.42
103200 68400 17.5
230580 169760 17.7
the deflation of the balloon and the retraction of the balloon catheter.
The final cyclic load step was constructed to represent the physiolog-
ical systolic and diastolic blood-pressure loads as well as the cyclic forces
exerted by the valve leaflets. This load step is described in more detail in
Section 5.8.
5.7 Analysis of Numerical Results
5.7.1 Mesh Convergence Analysis
In order to characterise the mesh sensitivity of the analyses and ensure
that an adequately sensitive mesh would be used, a simple deployment
analysis was conducted for both stent models. Linearly increasing pres-
sures of 0.0 - 1.25 MPa and 0.0 - 0.43 MPa were respectively applied to
the internal surfaces of Concept A and Concept B. This analysis was con-
ducted with various mesh sizes and the deviation in the deployed di-
ameter was compared with the variation in mesh size. The results for
Concept A and Concept B are displayed in Table 5.4 and Table 5.5 re-
spectively.
From the results given in Table 5.4 and Table 5.5, it can be seen that,
for Concept A, the difference between the deployed diameter for 61200
nodes and 230580 nodes was about 1.61%. 61200 nodes corresponded
to three elements along the width of the struts and five elements along
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Table 5.5: Concept B: Mesh Convergence Analysis
# Nodes # Elements Deployed Diameter
(mm)
7452 2612 22.22
29080 15696 16.6
71388 45190 17.64
118608 79890 17.72
140328 96450 17.76
Figure 5.4: Concept B: Mesh Configuration
the thickness of the struts. For Concept B, the difference between the
deployed diameter for 71388 nodes and 140328 nodes was about 0.7%.
71388 nodes also corresponded to three elements along the width of the
struts and five elements along the thickness of the struts. Thus, to reduce
the analysis time, while maintaining accurate results, the simulations for
both concepts were conducted with a mesh which corresponds to three
elements along the width of the struts and five elements along the thick-
ness of the struts. As an example of this configuration a section of the
finite element model used for Concept B is shown in Figure 5.4.
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Figure 5.5: Strut Thickness vs. Deployment Pressure
5.7.2 Effect of Strut Width on Radial Strength
As mentioned, the width of a stent’s struts in the circumferential direc-
tion has an influence on certain important characteristics of the stent,
such as stent profile, referring to the minimum crimp diameter, and ra-
dial strength. A number of simulations were conducted for the selected
concepts to investigate the influence of the variation in strut width on
the radial strength of the stents. For these simulations, the initial ex-
pansion process, crimping process and deployment to the functional di-
ameter were simulated for the strut widths as mentioned in Section 5.1.
The required pressure to achieve the functional diameter were recorded
against the variation in strut widths. Figure 5.5 displays a plot of the
strut width vs. the deployment pressure for both concepts.
From the figure it can be seen that both stent concepts display a more
or less linear relationship between the strut width and the required de-
ployment pressure. It is notable that Concept A requires a substantially
larger deployment pressure compared to Concept B. It can also be seen
that, in the case of Concept B, the deployment pressure displays a higher
sensitivity to a variation in strut width.
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Figure 5.6: Concept A: Minimum Crimped Diameter
5.7.3 Minimum Crimp Diameter
From the literature review it was determined that the crimped profile
of a percutaneous aortic valve plays a major role in the performance of
the device as it is directly related to the ease at which the device may
be guided through the arterial pathways of the body. It is therefore de-
sirable for the device to exhibit the minimum possible crimped profile.
Since the crimped profile of the device is directly related to the minimum
possible crimped profile of the stent component, simulations were con-
ducted to determine the relationship between the variation in strut width
and the minimum achievable crimped diameter for each concept. For the
simulations, stents with different strut widths were crimped with a rigid
cylinder to the minimum allowable crimped diameter - which was de-
fined as the diameter at which adjacent struts came into contact. The
minimum allowable crimped diameters for each concept are indicated in
Figure 5.6 and Figure 5.7. The areas of the struts that are in contact are
also indicated by the color spectrum.
The minimum crimped diameter for the different strut widths were
recorded and are displayed on the plot in Figure 5.8. From the figure it
can be seen that, for each concept, there exists a linear relationship be-
tween the variation in the strut width and the minimum crimp diameter.
It can also be seen that, for comparable strut widths, Concept A exhibits
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Figure 5.7: Concept B: Minimum Crimped Diameter
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Figure 5.8: Strut Width vs. Minimum Crimp Diameter
a slightly smaller crimped diameter. It should be noted that ultimately
the minimum possible crimped diameter of the assembled device will be
restricted by the valve leaflets, which will be assembled to the inside of
the stent, as well as the profile of the deployment balloon. Nevertheless,
the analysis was useful to indicate how each concept performed under
the crimping process as well as how the variation in strut width affected
the minimum possible crimped diameter.
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5.7.4 Analysis of Accumulated Stress and Strain
The software package CEI Ensight 8.2 was used to post-process the FEM
data generated by the simulations and extract the maximum true stresses
and strains across the stents for each increment of the assembly, crimping
and deployment load steps. Figures 5.9 and 5.10 show plots of the max-
imum true stresses induced in both concepts during the simulated load
steps. The true stress measure accounts for changes in the cross sectional
area by using the instantaneous values for areas, as opposed to engineer-
ing stress which uses the fixed undeformed cross-sectional area as a ref-
erence. The true stress measure provides a more accurate measurement
for events such as large deformations.
In Figures 5.9 and 5.10 the results for stents with different strut widths
are compared. For purposes of clarity the results for a strut width of 0.2
mm has been excluded for both concepts. From the figures it can be seen
that, for both concepts, the maximum induced stresses increase with an
increase in strut width. The effect of accumulated stress is also clearly
visible from the plots. For both concepts, it is important to evaluate the
safety factors against failure with respect to the true ultimate strength
of the material, which is 965 MPa. The safety factors against failure as
a function of strut width is given in Table 5.6. From the table it can be
seen that, for both concepts, the maximum induced true stress does not
exceed the true ultimate strength for any of the strut widths.
Figures 5.11 and 5.12 show plots of the maximum true plastic strain
induced in both stent concepts during the simulated load steps. Again,
in each plot the results for stents with different strut widths are com-
pared. For purposes of clarity the results for a strut width of 0.2 mm has
been excluded for both concepts. The effect of accumulated plastic strain
is also clearly visible from the plots. For both concepts, it is important
to evaluate the safety factors against failure with respect to the fracture
strain of the material, which is 0.48 or 48% [20]. The safety factors against
strain failure as a function of strut width is given in Table 5.7. From the
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Figure 5.9: Concept A: True Stress vs. Time
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Figure 5.10: Concept B: True Stress vs. Time
Table 5.6: Safety Factors against Stress Failure
Strut Width
.20 mm .23 mm .25 mm .27 mm
Concept A 1.80 1.65 1.54 1.50
.20 mm .22 mm .25 mm .27 mm
Concept B 1.77 1.75 1.44 1.37
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Figure 5.11: Concept A: True Strain vs. Time
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Figure 5.12: Concept B: True Strain vs. Time
Table 5.7: Safety Factors against Strain Failure
Strut Width
.2 mm .23 mm .25 mm .27 mm
Concept A 2.29 1.97 1.77 1.66
.20 mm .22 mm .25 mm .27 mm
Concept B 2.53 2.49 1.92 1.55
table it can be seen that, for both concepts, the maximum induced plastic
strain does not exceed the fracture strain for any of the strut widths.
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Figure 5.13: Concept A: Dog-
boning
Figure 5.14: Concept B: Coning
5.7.5 Deployment Characteristics
Deployment characteristics refer to the modes by which the stent con-
cepts deform during the deployment load step. These characteristics in-
clude modes of deformation, foreshortening and elastic recoil. An anal-
ysis of these characteristics are valuable to the designer as they help to
characterise the expected behavior of the concepts during deployment.
5.7.5.1 Mode of Deformation
The mode of deformation refers to the manner by which the concepts
deform from the crimped state to the deployed state. Figures 5.13 and
5.14 show the intermediate deformation states of Concept A and Concept
B during the deployment load step.
From Figure 5.13 it can seen that Concept A conforms to a "dog-
boning" deformation mode. The parameter that was defined to describe
the state of dog-boning during the deployment load step is given in
Equation 5.7.1.
Dog− boning = D
load
distal − Dloadcentral
Dloaddistal
(5.7.1)
Dloaddistal is the instantaneous diameter at the distal end of the stent and
Dloadcentral is the instantaneous diameter at the center of the stent. Figure
5.15 shows the defined "dog-boning" parameter as a function of the stent
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Figure 5.15: Concept A: Dog-boning vs. Central Outer Diameter
central outer diameter for the various strut widths. From the figure it can
be seen that dog-boning of the stent decreases slightly with an increase
in strut width.
It is also evident that the amount of dog-boning decreases linearly to
zero during the final stage of the deployment load step. This happens
as the central nodes catch up with the distal nodes, which have already
reached the predefined displacement constraint (see Section 5.5.1 for a
rationalisation of the deployment constraints placed on the outer nodes).
The phenomenon of a decreases in dog-boning during the final stage of
deployment also happens in practice (see Section 7.2.3).
From Figure 5.14 it can seen that Concept B conforms to a "coning" de-
formation mode. The parameter that was defined to describe the coning
mode of deformation is given in Equation 5.7.2.
Coning =
Dloaddistal − Dloadproximal
Dloaddistal
(5.7.2)
Again, Dloaddistal is the instantaneous diameter at the distal end of the
stent and Dloadproximal is the instantaneous diameter at the proximal end of
the stent. Figure 5.16 shows the defined "coning" parameter as a function
of the stent proximal outer diameter. For clarity purposes the results of
Concept B for a strut width of 0.20 mm was not included in the graph.
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Figure 5.16: Concept B: Coning vs. Outer Diameter
From the figure it can be seen that the level of coning is not dependent
on the strut width of the stent.
5.7.5.2 Elastic Recoil
Asmentioned in Section 1.4, elastic recoil refers to the elastic spring-back
of the stent after the deployment pressure has been removed. As men-
tioned in Section 5.6, after the deployment load step, the internal pressure
on the stent models was linearly decreased to allow for elastic recoil to
take place. Two recoil parameters were defined, namely longitudinal re-
coil and radial recoil. These parameters are described by Equations 5.7.3
and 5.7.4. It should be noted that, for Concept B, longitudinal recoil was
defined for the length of the stent containing struts, ignoring the three
support props which does not experience a change in length.
LongitudinalRecoil =
Lload − Lunload
Lload
(5.7.3)
Lload is the longitudinal length before load removal and Lunload is the
longitudinal length after load removal.
RadialRecoil =
Dload − Dunload
Dload
(5.7.4)
Dload is the outer diameter before load removal and Dunload is the
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Table 5.8: Concept A: Recoil Analyses
SW Lload Lunload Dload Dunload Longitudinal Radial
(mm) (mm) (mm) (mm) (mm) Recoil (%) Recoil (%)
0.20 17.499 17.635 20 18.791 -0.777 6.047
0.23 17.600 17.729 20 18.894 -0.733 5.53
0.25 17.818 17.941 20 18.877 -0.690 5.613
0.27 17.836 17.957 20 19.054 -0.678 4.730
Table 5.9: Concept B: Recoil Analyses
SW Lload Lunload Dload Dunload Longitudinal Radial
(mm) (mm) (mm) (mm) (mm) Recoil (%) Recoil (%)
0.20 16.414 16.443 20 18.488 -0.175 7.557
0.22 16.397 16.512 20 18.689 -0.702 6.557
0.25 16.424 16.515 20 18.7398 -0.554 6.301
0.27 16.461 16.532 20 18.801 -0.431 5.995
outer diameter after load removal. Recoil analyses were conducted for
both concepts to determine the effect of a variation of strut width on the
recoil parameters. The results of these analyses are given in Table 5.8 and
5.9. From the analyses it can be seen that the magnitude of the longitu-
dinal recoil parameters for Concept A are in the same range as those of
Concept B. It is also evident that, for both concepts, the longitudinal re-
coil decreases slightly with an increase in strut width. Both concepts also
exhibit radial recoil parameters of similar magnitude and radial recoil
decreases slightly with an increase in strut width.
5.7.5.3 Foreshortening
Foreshortening is defined as the amount by which a stent shortens, along
the longitudinal axis of the stent, during the deployment load step. The
equation that was used to describe the parameter for foreshortening is
given in Equation 5.7.5. It should be noted that, for Concept B, foreshort-
ening was defined for the length of the stent containing struts, ignoring
the three support props which did not experience a change in length.
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Table 5.10: Foreshortening Analyses
Concept SW Lcrimp L f inal Foreshortening
(mm) (mm) (mm) (%)
A 0.20 19.265 17.635 8.461
0.23 19.411 17.729 8.665
0.25 19.601 17.941 8.469
0.27 19.718 17.957 8.931
B 0.20 17.195 16.443 4.374
0.22 17.202 16.512 4.013
0.25 17.204 16.515 4.004
0.27 17.199 16.532 3.879
Foreshortening =
Lcrimp − L f inal
Lcrimp
(5.7.5)
Lcrimp is the crimped longitudinal length of the stent and L f inal is the
final deployed longitudinal length of the stent. Foreshortening analyses
were conducted for both concepts to determine the effect of a variation
of strut width on the foreshortening parameter. The results of these anal-
yses are given in Table 5.10. From the table it can be seen that, for both
concepts, foreshortening is not influenced significantly by a variation in
strut width. It is noteworthy that Concept A displays almost twice the
amount of foreshortening, compared to Concept B.
5.8 Stent Fatigue Analysis
Once the assembled valve is deployed into the desired position relative
to the native aortic valve, the stent component will be subjected to cyclic
loads as a result of the cyclic systolic and diastolic blood pressure as well
as the cyclic leaflet forces. For both concepts, a fatigue-life FEM analysis
was conducted to assess the relationship between the fatigue-life and the
strut width. A stress-life (S-N) analysis approach in combination with
the Modified Goodman Failure Criteria was selected as the methodology
that would be followed to perform the analyses [35; 36].
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The Modified Goodman Failure Criteria is a method used to plot the
midrange and alternating stresses against a predefined failure criterion,
known as the Modified Goodman Line. This method is often used for
analysis and design applications and is ideal for our application as it
may be easily graphed, it provides insight into the fatigue problem and
the answers may be scaled from the diagram as a check on the algebra.
5.8.1 Analysis of the Fatigue Loads
In order to perform the stress-life analysis for fatigue loading, the gov-
erning fatigue loads had to be analysed. In a thesis report by Van Aswe-
gen on the Dynamic Modeling of a Stented Aortic Valve, the effect of the
dynamic pressure difference across the valve on the forces exerted by the
valve leaflets were analysed [4]. In the paper a worst case scenario was
investigated with a maximum pressure difference of 180 mmHg. Fig-
ure 5.17 shows the resulting dynamic pressure that was recorded, by a
fluid-structure analysis, on the aortic side of the valve. The total resul-
tant reaction forces exerted by the valve leaflets during a single cardiac
cycle were also analysed in the thesis and the results are given in Figure
5.18. The simulation was conducted for a heart rate of 60 bpm. Since
it was possible to formulate a symmetry-solution problem, only half of a
single leaflet was simulated. The simulation indicated that the maximum
radial force exerted by a single valve leaflet is 1.7 N, while the maximum
axial force exerted is 1.74 N. In a thesis report by Smuts on the Investi-
gation of Tissue Materials for Implementation in a Percutaneous Aortic Heart
Valve, the distribution of the valve leaflet reaction forces were simulated
using FEM [5]. The result of this simulation indicated that approximately
37% of the total reaction forces were concentrated at the top of the valve
leaflet, while the remaining component of the reaction forces were more
or less evenly distributed along the rim of the leaflet. For this thesis, only
the parabolic assembly configuration was considered with respect to the
fatigue analysis as both assembly configurations appeared to exert simi-
lar reaction forces. The results of the FEM analysis conducted by Smuts
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Figure 5.17: Dynamic Pressure Difference Across Aortic Valve [4]
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Figure 5.18: Valve Leaflet Force for a Half Leaflet [4]
are indicated in Figure 5.19.
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Figure 5.19: Valve Leaflet Force Distribution [5]
5.8.2 Simulation of Fatigue Loading
For the fatigue loading simulations, the discrete deformation modes, as
described in Section 5.6, was first modeled to induce the steady state
stresses in the models. The discrete deformation modes were followed
by the fatigue load step. Since the deployed stent will be located on the
aortic side of the valve leaflets, a dynamic pressure according to Figure
5.17 was applied to the internal surface of the stent to simulate the phys-
iologic pressure cycle. For the leaflet reaction forces the results of the
analysis by A. Smuts was used to formulate the force distribution across
the stent. Therefore, along with the physiologic pressure cycle, a time-
dependent force according to Figure 5.18 was distributed according to
Figure 5.19 along the nodes on the models that corresponded to the as-
sembly line between the stents and the valve leaflets.
CHAPTER 5. NUMERICAL SIMULATIONS 55
Figure 5.20: Diagram of MATLAB Script: Calculation of Fatigue Safety Factor
5.8.3 Fatigue Loading: Analysis of Results
According to literature the endurance limit (Se) of stainless steel 316L is
260 MPa [37]. For the cyclic loading, as discussed in Section 5.8.2, the
mean stress (σm) and stress amplitude (σa) were calculated for each ele-
ment across the stent. The mean stress and stress amplitude were calcu-
lated from the predicted maximum principle stresses according to Equa-
tions 5.8.1 and 5.8.2 [36].
σm =
σmax + σmin
2
(5.8.1)
σa =
∣∣∣∣σmax − σmin2
∣∣∣∣ (5.8.2)
AMATLAB script was written to process the generated finite element
data and calculate the fatigue life parameters for each of the strut widths.
The code for theMATLAB script can be found in Appendix E. A diagram
which shows the program flow of the MATLAB script is shown in Figure
5.20.
The calculated mean stress and stress amplitude for each element
across the stent are shown as the blue dots in Figure 5.21 for Concept
A (strut width = 0.23 mm) and Figure 5.22 for Concept B (strut width =
0.25 mm). In order to maintain the flow of the text, results of the MAT-
LAB analyses for the remaining strut widths can be found in Appendix
F.
The predicted mean stresses and stress amplitudes were used to cal-
culate a Fatigue Safety Factor (FSF) distribution by utilizing theModified
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Figure 5.21: Concept A: Fatigue Diagram - Strut Width 0.23 mm
Goodman Failure Criteria. The FSFs give an indication of the proximity
of the mean stress and stress amplitude at each numerical integration
point to the Modified Goodman Line, which is also indicated in Figures
5.21 and 5.22. The "×" in each figure shows the data point which lies
nearest to the Goodman Line and represents the element most suscep-
tible to fatigue failure. The equation that defines the FSF for each nu-
merical integration point is given in Equation 5.8.3, with Sut being the
ultimate true tensile strength [35].
σa
Se
+
σm
Sut
=
1
FSF
(5.8.3)
For both concepts the worst case FSFs, as represented by the "×" in
the figures, are given in Tables 5.11 and 5.12.
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Figure 5.22: Concept B: Fatigue Diagram - Strut Width 0.25 mm
Table 5.11: FSF: Concept A
Strut Width Mean Stress Stress Amplitude Fatigue Safety
(mm) σm (MPa) σa (MPa) Factor (FSF)
0.20 462.91 55.15 1.45
0.23 354.99 70.74 1.56
0.25 487.07 31.93 1.59
0.27 497.44 23.67 1.65
Table 5.12: FSF: Concept B
Strut Width Mean Stress Stress Amplitude Fatigue Safety
(mm) σm (MPa) σa (MPa) Factor (FSF)
0.20 300.66 104.56 1.40
0.22 283.14 86.65 1.59
0.25 231.68 93.48 1.67
0.27 219.74 93.46 1.70
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Table 5.13: Sensitivity Analysis
Parameter FSF # of iterations Analysis Time
(hours)
Default Parameters 1.67 82 5.22
Modified Newton-Raphson 1.68 218 9.99
Large Strain Multiplicative 1.69 99 4.41
Direct Profile 1.67 82 12.21
FSF = Fatigue Safety Factor
From the tables it can be seen that, for both concepts, an increase in
strut width represents an increase in resistance to fatigue. The impact of
the results reported in this section, is discussed in the Section 5.10.
5.9 Sensitivity Analysis
A sensitivity analysis was conducted to determine the stability of the
simulation results with respect to the selected solution parameters. The
sensitivity of the simulation results were investigated with respect to the
following parameter changes:
• The iterationmethodwas changed from theNewton-Raphsonmethod
to the Modified Newton-Raphson method
• The plasticity procedure was changed from Large Strain Additive
to Large Strain Multiplicative
• The solver was changed from Multifrontal Sparse to Direct Profile
The results of the sensitivity analysis for the fatigue simulation of
Concept B (strut width of 0.25 mm) is given in Table 5.13.
The results of the sensitivity analysis confirmed the stability of the
simulation setup. It can be seen that the simulations were not particu-
larly sensitive to a variation of the analysis parameters. The Direct Pro-
file solver yielded exactly the same results as the Multiplicative Sparse
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solver, however the analysis time was much slower. Selection of the
Large Strain Multiplicative procedure resulted in a decrease of the anal-
ysis time while the FSF only changed marginally.
5.10 Discussion of Numerical Results
5.10.1 Concept A vs. Concept B
It can be seen from the geometric parameters of the stent concepts (Sec-
tion 5.1) that Concept A exhibits a lower metal-to-surface area ratio com-
pared to Concept B. It can also be seen that Concept A has a shorter de-
ployed length. The geometric parameters indicate that Concept A has a
lower profile when compared to Concept B. This is advantageous as it is
desirable for the valve device to have the lowest profile possible. Note
that the overall undeformed length and deployed length for Concept B is
the same. This may be attributed to the fact that the three support struts
do not experience a change in length during the various deformation
modes.
For Concept A, a considerably higher pressurewas required to deploy
the stent to the functional diameter (Section 5.7.2). A higher deployment
pressure implies a higher radial strength. A high radial strength is ad-
vantageous as it provides an increased resistance to radial compressive
forces. A high deployment pressure, however, has the disadvantage that
deployment by manual pressurisation becomes more difficult and risk
factors such as uneven deployment as well as balloon rupture comes into
play.
Concept A exhibits a slightly smaller crimp diameter as compared
to Concept B (Section 5.7.3). Crimp diameter plays a major role in the
performance of the valve device as it determines the ease with which
the device may be guided through the arterial pathways. In this regard,
Concept A is superior to Concept B.
An analysis of the accumulated stresses and strains indicated that,
for the same strut widths, both concepts exhibited similar safety factors
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against failure (Section 5.7.4). As the problem at handwas regarded as an
induced strain problem as opposed to an induced stress problem, atten-
tion was given to the safety factors against strain failure. Since Concept B
exhibited slightly larger safety factors against strain failure for compara-
ble strut widths, Concept B presented a superior concept is this respect.
An analysis of the mode of deformation (Section 5.7.5.1) indicated
that Concept A and Concept B exhibited entirely different deployment
deformations. As mentioned, Concept A exhibited a "dog-boning" defor-
mation mode, while Concept B exhibited a "coning" deformation mode.
Although the actual impact of these deformation modes on the ease and
effectiveness of in-vivo deployment was difficult to predict, it is evident
that a "dog-boning" deformation mode might result in a self-positioning
phenomenon, which would be advantageous. No inherent advantages
could be foreseen regarding the "coning" deformation mode.
The analysis of the elastic recoil (Section 5.7.5.2) indicated that the lon-
gitudinal recoil for both concepts were less than 1%, which would have
a negligible impact on the performance of the stents. Radial recoil is an
important parameter with respect to stent performance. It is desirable for
a stent to exhibit a minimal radial recoil, because radial recoil will coun-
teract the anchoring of the device within the aortic annulus. For similar
strut widths, Concept A showed slightly less radial recoil as compared
to Concept B.
It is predicted that foreshortening of the stent will play a significant
role in the performance of the valve device as it will influence the amount
of strain transferred from the sutures to the valve leaflets during the de-
ployment process. Since the sutures will be displaced along with the
struts of the stent during the deployment step, a significant amount of
foreshortening might lead to high stresses and unnatural deformations
induced in the leaflets. An analysis of the foreshortening induced in both
concepts (Section 5.7.5.3) indicated that Concept A would experience ap-
proximately twice the percentage of foreshortening compared to concept
B. With respect to foreshortening, the analysis indicated that Concept B
showed superior performance compared to Concept A.
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An analysis of the resistance to fatigue failure (Section 5.8) indicated
that for similar strut widths, both concepts exhibited very similar resis-
tances to fatigue failure. Since a worst-case fatigue loading scenario was
investigated with physiologic conditions that is very unlikely to occur
in an actual situation, a fatigue safety factor in the range of 1.4-1.7 was
deemed sufficient. Since both concepts exhibited similar resistances to
fatigue, neither concepts appeared to be superior in this regard.
A summary of the most significant results from the numerical analy-
ses is given in the following list:
• Concept A exhibits a comparatively lower metal-surface area ratio.
Metal-surface area ratio is directly related to the amount of metal
placed inside the patient per surface area. It is desirable to have a
minimum metal-surface area ratio as to reduce the bulkiness of the
device as well as to improve the bio-compatibility of the device.
• Concept A has a shorter deployed length. A short deployed length
is advantageous as it reduces possible interference with the coro-
nary arteries.
• Concept A has a smaller crimp diameter and lower profile.
• Concept A exhibits a comparatively higher radial strength.
• Concept B exhibits a comparatively higher safety factor against strain
failure.
• Concept A conforms to a dog-boning deloyment mode, whereas
Concept B conforms to a coning deployment mode.
• Concept A shows comparatively less radial recoil.
• Concept B shows comparatively less foreshortening.
CHAPTER 5. NUMERICAL SIMULATIONS 62
5.10.2 Selection of Strut Width
With respect to the selection of a strut width for the final design, for
some of the parameters discussed in the preceding sections, a thinner
strut width is preferred, while for others a thicker strut width is advan-
tageous. Therefore, when selecting a strut width, a compromise much
be reached between the parameters. Therefore a careful consideration of
the importance of each parameter is required with respect to each of the
concepts.
5.10.2.1 Concept A
Since Concept A presents an inherently larger radial strength, a smaller
strut width is desirable to achieve a realistic deployment pressure. This
will also be a benefit for the minimum crimp diameter and strains in-
duced within the stent. The FEM analyses indicated that the amount
of dogboning increases slightly with an increase in strut width. As dis-
cussed, with respect to the stent application a fair amount of "dogboning"
is desirable, however too much dogboning might also result in poor per-
formance. With respect to Concept A, the strut width has a limited effect
on both the amount of radial recoil and foreshortening. A larger strut
width will be beneficial to the resistance against fatigue failure. In or-
der to obtain a reasonable deployment pressure and minimise the crimp
diameter and induced strains, while achieving a reasonable amount of
dogboning and an FSF of at least 1.56, a strut width of 0.23 mm was se-
lected for the final design.
5.10.2.2 Concept B
Since Concept B exhibits an inherently smaller radial strength, a larger
strut width would be required to achieve a deployment pressure and ra-
dial strength comparable with Concept A. As is the case with Concept
A, a smaller strut width will allow for a smaller achievable crimp di-
ameter as well as smaller induced strains. The analyses indicated that
the amount of "coning" was not dependent on the strut width. With re-
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spect to Concept B, the amount of radial recoil as well as foreshortening
decreases slightly with an increase in strut width. A larger strut width
will also be beneficial to the resistance against fatigue failure. In order
to achieve an improved radial strength, while maintaining a reasonable
crimp diameter, a slightly larger strut width was selected compared to
Concept A. A strut width of 0.25 mm was selected for Concept B, since
the larger strut width also resulted in less radial recoil and foreshorten-
ing, which was desirable. The selected strut width gave a safety factor
against fatigue of 1.67, being slightly larger as compared to Concept A.
Chapter 6
Manufacturing and
Electropolishing
6.1 Manufacturing of Stent Prototypes
Stent manufacturing is a highly specialised field, which involves high
costs and requires advanced manufacturing equipment. As a result, for
the first protoype development phase, only 10 prototype stents wereman-
ufactured for each of the two final designs selected in Section 5.10.2. The
stent prototypes were laser cut courtesy of Disa Vascular (Pty) Ltd, a
leading South African stent manufacturing company. Figures 6.1 and 6.2
show photos of the two designs that were selected for prototype manu-
facturing.
6.2 Electropolishing
6.2.1 Introduction
The manufacturing of stents by the laser cutting process results in the
stents having sharp edges. It is therefore common practise in the stent
manufacturing industry to electropolish stents following the cutting pro-
cess. This is done to remove sharp edges and surface irregularities, to
64
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Figure 6.1: Concept A: Prototype
Stent
Figure 6.2: Concept B: Prototype
Stent
control surface levelling and to improve surface smoothness. The pro-
cess may be controlled by varying the following parameters [38]:
• Voltage potential and applied current
• Electrolite composition and concentration
• Electrolite temperature
• Processing time
• Hydrodynamics (agitation, cell configuration and geometry)
• The untreated surface quality
6.2.2 Electropolishing Parameter Setup
According to a representative of Disa Vascular (Pty) Ltd, the company’s
research indicated that the following electrolite composition (by weight)
works well to electropolish stents manufactured from stainless steel 316L
[39]:
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• 40 parts: 85% Phosphoric acid
• 39 parts: 99% Glycerol
• 11 parts: Deionised water
The representative also recommended the following processing pa-
rameters as a starting point:
• Voltage potential: 15 V
• Electrolite temperature: 70 ◦C
• Processing time: 1-2 minutes, depending on the amount of stock
removal required
Since Disa Vascular has about 10 years of experience regarding stent
manufacturing and electropolishing, it was decided that their parameter
recommendation would be used as a starting point for the electropolish-
ing process.
6.2.3 Electropolishing Process Setup
Figure 6.3 shows a diagram of the setup that was used to conduct the
electropolishing process.
The heated magnetic stirrer plate contains a rotating magnet which
agitates the stirrer magnet placed inside the glass beaker. The electro-
lite temperature and agitation could therefore be controlled by the stirrer
plate. A piece of thin 316L sheet metal was rolled up to form a roughly
tubular structure and placed inside the beaker to act as the cathode. The
stent, which acted as the anode, was suspended from a Tungsten wire
into the center of the immersed cathode tube to ensure that it saw an
equal electric field. The cathode tube was connected to the negative ter-
minal and the stent to the positive terminal of a 20 V 5 A DC power
supply.
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Figure 6.3: Electropolishing Process Setup
6.2.4 Electropolishing Results
Figure 6.4 shows a magnified image of a section of one of the untreated
prototype stents. From the figure it can be seen that the untreated stent
had a fairly poor surface finish and that the surface contained irregulari-
ties and impurities. This could be attributed to the fact that non-medical
tubing was used to manufacture the stents. It was expected that, as a
result of the poor untreated surface finish, the advantageous outcome of
the electropolishing process would be limited.
Since the geometries of the stent designs were set, the outcome of the
electropolishing process would be determined by the electrolite temper-
ature, voltage potential, agitation and processing time. Since these four
parameters could yield an endless number of possible combinations, it
was decided that the agitation and voltage potential would be set, while
the temperature and processing time would be varied in an attempt to
achieve satisfactory electropolishing results. A number of tubing off-cut
samples were used to experiment with the variable parameters. The re-
sults of these experiments are presented in Appendix D. The results of
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Figure 6.4: Untreated Stent - 100x Magnification
these samples indicated that pitting (formation of crevices) of the sur-
face started immediately at the onset of the electropolishing process and
was unavoidable. It appeared that this may be attributed to the poor un-
treated surface finish. It also appeared as though a variation in temper-
ature had a greater influence on the results as compared to a variation
in processing time. The results of the samples were used as a basis to
investigate the parameters that would give the best possible surface fin-
ishes for the prototype stents. The aim was to brighten the surface and
smoothen the edges without compromising the stent structure. The pa-
rameters that worked best for the stent prototypes are given in Table 6.1.
Figures 6.5 and 6.6 showmagnified sections of stent prototypes that were
electropolished with these parameters.
Although the results obtained are far from optimal, the electropolish-
ing process aided in smoothing the sharp stent edges, which would oth-
erwise present a possible threat to balloon rupture as well as suture and
leaflet damage. It can also be seen from the results that the processing
time for Concept A is considerably higher compared to the processing
time for Concept B. This could be attributed to the difference in stent
geometry.
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Table 6.1: Stent Prototype Electropolishing Parameters
Voltage Agitation Temperature Processing
(V) (◦C) Time (s)
Concept A 16 3/6 85 240
Concept B 16 3/6 78 135
Figure 6.5: Microphotograph of
Concept A Prototype: Polished Sur-
face
Figure 6.6: Microphotograph of
Concept B Prototype: Polished Sur-
face
6.3 Assembly of Valve Prototypes
Although the assembly of the valve prototypes did not form a part of
this thesis, a photo of each of the assembled concepts is included in this
section to confirm the compatibility of the concepts with the respective
assembly configurations. The valve prototypes were assembled by Mr.
A. Smuts as part of his Master’s thesis. Figure 6.7 shows one of the proto-
types that were assembled according to Concept A and Figure 6.8 shows
one of the prototypes that were assembled according to Concept B.
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Figure 6.7: Concept A - Assembled
Prototype
Figure 6.8: Concept B - Assembled
Prototype
Chapter 7
Experimental Analysis
In order to perform an initial evaluation of the performance and charac-
teristics of the manufactured prototype stents, the discrete deformation
and loading modes to which the stents will be subjected during assem-
bly and deployment (Section 5.6) were experimentally replicated in an
in-vitro environment. The experimental results also served to evaluate
the reliability of the finite element simulations.
7.1 Experimental Procedure
The simulated deformation and loadingmodeswere experimentally repli-
cated by performing the steps described in this section. For each of the
steps, the distal, proximal and central outer diameters as well as the
lengths of the stents were measured at regular intervals by means of a
digital vernier caliper.
7.1.1 Rigid Expansion Process
The initial rigid expansion of the stents was achieved by advancing the
stents across a stainless steel polished tapered rod, which was specifi-
cally manufactured for this purpose. The diameter of the tapered rod
increased from 8 mm to 20.2 mm at a taper angle of 1.06 degrees. The
stents were slightly over expanded to compensate for elastic radial re-
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Figure 7.1: Photo of Taper Expansion Setup
coil. To achieve this process, the stents were first attached to a PVC ring
with strong sutures. The PVC ring was subsequently advanced over the
tapered rod to achieve an even expansion of the stents. Graphite powder
was used as a lubricant. Figure 7.1 shows a photo of the setup that was
used for the rigid expansion process. Figure 7.6 (Section 7.2.2) shows a
diagram of the rigid expansion process.
7.1.2 Crimping Process
The crimping process was achieved by crimping the stents onto a balloon
catheter by hand. The first phase of the hand crimping was achieved by
crimping the stents against the tapered stainless steel rod, which served
as a crimping guide. The final phase of the hand crimping was achieved
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Figure 7.2: Concept B Prototype: Crimped State
by crimping the stents, over a thin pericardium sheath, onto the balloon
catheter. The sheath served to represent the valve leaflets as well as pro-
tect the balloon from rupture. Figure 7.2 shows the crimped state for one
of the prototypes of Concept B.
7.1.3 Deployment Process
As described in Section 7.1.2, the prototype stents were crimped onto a
low-compliance NuMedTM PET (polyester polyethylene terephthalate)
balloon catheter with a rated deployment diameter of 18 mm and a burst
pressure of 6 bar. Prior to the deployment step, the balloon catheter was
filled with saline and flushed to remove any trapped air bubbles. Subse-
quently, the stents were gradually deployed to the deployment diameter
by increasing the pressure through a syringe, which was connected to the
corresponding catheter port. The deployment pressure was monitored
using a pressure gage, connected to a side port. Figure 7.3 shows a photo
taken during the deployment process for a prototype stent of Concept A.
7.1.4 Elastic Recoil
After the deployment process, the internal balloon pressurewas removed
to allow for the elastic recoil of the stents.
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Figure 7.3: Concept A Prototype: Deployment Process
7.1.5 Fatigue Loading
In order to evaluate the resistance of the stents to the fatigue loads, as
would be typically experienced by the stents in an in-vivo environment,
it was initially proposed that the assembled valves be subjected to accel-
erated fatigue tests in a pulse duplicator. A pulse duplicator is a machine
which simulates the pumping action of the left ventricle. The design and
construction of a pulse duplicator formed part of anotherMaster’s thesis.
Unfortunately, at this point in time, the pulse duplicator still experiences
some technical difficulties during operation which prevents it from oper-
ating for extended periods of time. Therefore, fatigue tests could not yet
be conducted and the fatigue simulations could not be validated.
7.2 Discussion of Experimental Results
7.2.1 Stent Deployment Process
Figures 7.4 and 7.5 show, for both concepts, plots of the distal outer diam-
eters vs. deployment pressures for the experimental data as well as the
simulation results. From the plots it can be seen that, for both concepts,
the simulated deployment pressure is considerably higher compared to
the actual required deployment pressure. It seems probable that this may
be attributed to the effect of the outward vectored forces of the bulging
balloon membrane, in between the struts, that is not taken into account
in the finite element simulations [40]. During the actual deployment of
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Figure 7.4: Concept A Prototype: Deployment Pressure vs. Displacement -
Comparison of Results
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Figure 7.5: Concept B Prototype: Deployment Pressure vs. Displacement -
Comparison of Results
the stent a load of unknown magnitude is transferred by the membrane
to the stent as the balloon expands. The results could therefore not be
used to verify the validity of the simulations.
The results could however be used to indicate the actual pressure
required to deploy the stents. The experimental results confirmed that
Concept A required a larger deployment pressure, as suggested by the
finite element simulations. The deployment pressure for Concept A was
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0.25 MPa, while the deployment pressure for concept B was 0.2 MPa.
The deployment pressure was taken as the point at which the required
deployment pressure was no longer dominated only by the resistance
from the stents, but also by the resistance of the balloon, as it neared its
nominal deployment pressure (Symbol "B" in the figures).
It should also be noted that there existed a correlation between the
simulation data and experimental data for the diameters at which the
stents experienced a transition from the elastic deployment deformation
to plastic deployment deformation, indicated by symbol "A" in the fig-
ures.
For both the simulation and experimental data, symbol "C" indicates
the amount of elastic radial recoil which takes place when the deploy-
ment pressure is removed.
7.2.2 Rigid Expansion Process
As a result of the fact that the experimental results of the deployment
process failed to validate the finite element simulations, an experiment
had to be designed to verify the validity of the simulations. For this
purpose an experimental setup was constructed to measure the reaction
force applied to the tapered expansion rod as the stents were expanded
by advancing them across the rod.
For this experimental setup, the tapered rod was mounted to a 500 N
load cell and the force required to advance the stents across the rod was
recorded, using a SPIDERTM bridge amplifier / data acquisition system,
against the instantaneous translated distance along the rod. Although
only a small part of the load cell range was used, a calibration test was
conducted which indicated that the load cell was linear and accurate in
this range. Graphite powder was used as a lubricant. Figure 7.6 shows a
diagram of the experimental setup that was used.
For both stent concepts, this process was also subjected to a finite ele-
ment analysis. Since the coefficient of friction between the stents and the
taper was an unknown variable, the simulations for both concepts were
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Figure 7.6: Diagram of Taper Expansion Process
conducted for different friction coefficients.
The experimental results as well as the results of the finite element
simulations for different coefficients of friction are given for Concept A
in Figure 7.7 and for Concept B in Figure 7.8. From these results it can
be seen that for Concept A, a coefficient of friction of 0.085 correlated
well with the experimental results, while for Concept B a coefficient of
friction of 0.1 correlated well with the experimental results. These re-
sults indicated that the geometric models, mesh densities and material
properties used to describe the FEM models could, to a certain extent,
be implemented in finite element analyses to predict the behavior of the
concepts.
7.2.3 Modes of Deployment
For Concept A, the "dog-boning" effect (Equation 5.7.1) is plotted as a
function of central outer diameter in Figure 7.9 for both the experimental
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Figure 7.7: Concept A: Rigid Expansion - Comparison of Results
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Figure 7.8: Concept B: Rigid Expansion - Comparison of Results
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Figure 7.9: Concept A: Dog-boning - Comparison of Results
results as well as simulated results. From the figure it can be seen that the
maximum dog-boning for the experimental results is somewhat higher
compared to the simulation data. It is again plausible that the effect of
the balloon membrane played a role in the deviation of the experimental
results from the simulation data. Other factors such as non-uniform strut
width may also have attributed to the discrepancy between the data sets.
For Concept B, the coning effect (Equation 5.7.2) is plotted as a func-
tion of the stent outer diameter in Figure 7.10 for both the experimental
results as well as the simulated results. From the figure it can be seen
that the maximum coning for the experimental results is slightly higher
compared to the simulation data. Apart from the discrepancy between
themaximum coning, the experimental data correlates well with the sim-
ulation data.
7.2.4 Crimp Diameter, Foreshortening and Recoil
The parameters for minimum crimp diameter, foreshortening and elas-
tic recoil were also compared for the simulation data and experimental
data. The results for the comparison is given in Table 7.1. The deviation
of the simulation data from the experimental results is also given as a
percentage in the table. From the comparison of the simulation data and
experimental data it can be seen that the simulations predicted the min-
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Figure 7.10: Concept B: Coning - Comparison of Results
Table 7.1: Parameter Comparison: Experimental Data vs. Simulation Data
Simulation Experimental
Concept A Results Results Deviation (%)
Min. Crimp Dia. (mm) 4.64 4.71 1.5
Foreshortening (%) 8.67 10.12 14.3
Radial Recoil (%) 5.53 5.20 6.3
Longitudinal Recoil
(%)
-0.86 -0.92 6.5
Simulation Experimental
Concept B Results Results Deviation (%)
Min. Crimp Dia. (mm) 5.43 5.27 3.0
Foreshortening (%) 4.00 3.54 13.0
Radial Recoil (%) 6.30 6.03 4.5
Longitudinal Recoil
(%)
-0.55 -0.49 12.2
imum crimping diameter to an accurate degree. For both concepts the
parameter for foreshortening was predicted to the least accurate degree.
This was unexpected as foreshortening is a geometry dependent parame-
ter as opposed to a material dependent parameter and a higher accuracy
would be expected. The parameters for recoil were predicted within an
13% margin, which, from an engineering point of view, is a reasonable
deviation.
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7.3 Conclusion to the Experimental Analysis
Although there were some discrepencies between the data obtained from
the simulations and the experimental results, the experimental analysis
served to provide a good insight into the actual performance character-
istics of the concepts as well as to provide insight into the value of finite
element simulations with respect to stent design and development.
From the experimental analysis, the actual required deployment pres-
sure was determined, the mode of deployment for each concept was
evaluated and other stent characteristic were measured. The knowledge
gained from the experimental analysis will be invaluable for continued
prototype development and refinement.
Chapter 8
Conclusion
The literature review indicated that the development of a percutaneous
aortic heart valve is an intricate process which is extremely time con-
suming and costly. It is therefore imperative that modern technologies
be implemented to reduce the number of design iterations required to
develop a functional device. Since the finite element method provides an
cost and time effective tool to perform structural analyses, it was the ob-
jective of this thesis to implement this technology to develop, taking into
account time and cost efficiency, a first prototype for the stent component
of a percutaneous aortic heart valve, which would serve as the stepping
stone towards continued product development.
In order to achieve this objective a number of stent concepts were gen-
erated. The two most promising concepts were subjected to comprehen-
sive finite element analyses of the deformations and forces experienced
by the stent during implantation and operation. For each of the most
promising concepts, the simulations were conducted for different strut
widths to determine the strut width that would be most suited for the
specific stent application. The results of the FEM simulations indicated
that a variation in strut width had a substantial influence on stent charac-
teristics such as radial strength, crimp diameter, stress and strain, elastic
recoil and fatigue. Stent characteristics such as mode of deformation and
foreshortening were less influenced by strut width. The results also indi-
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cated that the selection of stent geometry had a major influence on stent
performance.
From the results of the FEM analyses a strut width was selected for
each concept and a number of prototypes weremanufactured. The proto-
types were subjected to experimental analyses to evaluate the relevance
of the FEM analyses as well as to evaluate the actual stent performance.
Although the FEM analyses were able to predict some of the stent char-
acteristic to a fairly accurate degree, the overall performance of the stents
were compromised by non-uniform strut width and poor surface fin-
ishes. The use of non-medical grade tubing resulted in non-uniform strut
widths due to the fact that the laser beam had trouble maintaining a pin-
point focus on the tubing which had a low concentric tolerance. An im-
portant conclusion that may be drawn from this result is that the use of
high grade medical tubing is vital for optimal stent performance.
The most significant conclusion that could be drawn from the finite
element simulations and experimental work was that Concept A is the
most promising stent design. For comparable strut widths, Concept A
showed a lowermetal-surface area ratio, a higher radial strength, a smaller
crimp diameter and slightly less radial recoil. Concept Awas compatibile
with the parabolic leaflet assembly configuration, which is the configu-
ration which most accurately resembles the native aortic valve. Concept
A also exhibited a dog-boning deployment mode, which might be ben-
eficial to the positioning of the device. A single drawback of Concept
A was that it exhibited a greater amount of foreshortening compared to
Concept B. However, testing of the prototype valves assembled by Mr.
A. Smuts indicated that this was not a significant drawback.
An additional conclusion that can be drawn is that the electropolish-
ing process failed to achieve a significant improvement of the fairly poor
surface quality of the metal tubing used. As a result of this, the optimal
electropolishing parameters for the specific stent geometries could not be
determined.
Through the research conducted, the author gained experience in the
simulation of non-linear finite element problems. A better understanding
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was also achieved regarding the aspects involved in the development of
a percutaneous aortic heart valve and knowledge was gained regarding
the design parameters that determine stent performance characteristics.
As a step towards developing a functional product, an application for
a provisional patent has been submitted for a percutaneous aortic heart
valve which utilises Concept A.
Chapter 9
Limitations and
Recommendations
The work done in this Master’s thesis served as a stepping stone towards
the development of a percutaneous aortic heart valve that will eventually
be suitable for implantation in human beings. It is therefore vital that
the knowledge gained through the research conducted be transferred to
the entity that will continue the research and development of the device.
The goal of this section is therefore to highlight the limitations of the
current work as well as provide recommendations for future research on
the subject.
9.1 Limitations to the Work
The following limitations to the current work were identified:
• The external environment, such as the radial reaction force exerted
by the aortic annulus, was not considered for finite element simu-
lations.
• The effect of the bulging balloon-membrane on the deployment of
the stents was not considered for the finite element simulations.
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• The simulations and experimental work was conducted for stain-
less steel instead of the more superior cobalt-chrome alloy, MP35N
of L605.
• The effect of a variation in strut thickness was not considered.
• Fatigue performance of the prototypeswere not evaluated in a pulse
duplicator.
9.2 Recommendations
Based on the results and limitations to the work, the following recom-
mendations can be made for continued development of a fully functional
percutaneous aortic valve replacement:
• Since the results of the present work indicated that Concept A is the
most promising concept, it is recommended that continued devel-
opment of the prototype be focused on this concept.
• Medical grade cobalt-chrome (MP35N) tubing must be used in-
stead of lower grade stainless steel to manufacture the prototypes.
• Since cobalt-chrome exhibits slightly superior properties compared
to stainless steel, it is recommended that the design for Concept A
be slightly altered prior to the next round of prototype manufactur-
ing. It is recommended that the strut thickness and strut width be
slightly reduced. Also, since the actual deployed length of the pro-
totype stent was slightly less compared to the simulated deployed
length, the overall length of the stent may be slightly increased. The
suggested dimensions for the next round of prototype manufactur-
ing is given in Figure G.1 of Appendix G. The main purpose of
these alterations is to give a slight reduction in deployment stiff-
ness, as the experimental results indicated that the present design
is slightly too stiff.
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• The optimal electrolyte composition and electro-polishing parame-
ters must be determined for a prototype stent manufactured from
cobalt-chrome.
• A suitable test-rig must be designed and constructed to improve
the accuracy of the experimental results.
• A crimping tool must be developed that is capable of achieving the
uniform crimping of the assembled prosthesis.
• A delivery system must be developed and manufactured that is
compatible with the valve prosthesis being developed.
• In-vitro fatigue tests must be conducted for the assembled proto-
type valves.
• The animal trial phase must be initiated.
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Appendix A
Stent Design Concepts
A.1 Stent Concept: Design 1
The concept for Design 1 was based on the Palmaz-Schatz [40; 41; 42; 43]
coronay stent from Johnson & Johnson Medical Devices. This design
consists of a tube with simple square slots which appear like diamond
shaped cells after expansion. Figure A.1 and Figure A.3 respectively
shows the undeformed initial geometry and fully expanded configura-
tion of the stent. Due to the cyclic radial symmetry of the stent, the initial
expansion, crimping and rigid deployment process was simulated for
only one seventh of the stent. The results of the simulation was then re-
volved to show the complete stent. From Figure A.3 it can be seen that
the stent has 14 distal protrusion annexes. However the three leaflets of
the valve assembly require three assembly joints, equi-spaced around the
diameter of the stent. For this reason, an ideal stent for the assemblymust
have a number of distal protrusion annexes which is a multiple of three.
The total equivalent plastic strain after the deployment process is in ex-
cess of 60% (see Figure A.3) and the strain-limit of Stainless Steel 316L is
43%. Figure A.2 shows the crimped state of the stent. From the figure,
it can be seen that the stent experiences severe non-uniform deformation
during the crimping process. Given the factors discussed in the previ-
ous paragraph, it is apparent that this stent design is not suitable for a
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Figure A.1: Stent Design 1: Undeformed State
percutaneous aortic valve application, and the design was subsequently
rejected as a feasible concept.
A.2 Stent Concept: Design 2
The concept for Design 2 was based on the stent used in the Edwards
SAPIEN Transcatheter Heart Valve from Edwards Life Sciences [29]. This
design consists of three support props, which serve as assembly joints for
the three leaflets of the valve. The support props are connected with two
sets of mirrored zig-zag shaped struts, which enable the crimping and
expansion of the stent. Figure A.4 and Figure A.6 respectively shows
the undeformed initial geometry and fully expanded configuration of
the stent. Due to the cyclic radial symmetry of the stent, the initial ex-
pansion, crimping and rigid deployment process was simulated for only
one third of the stent. The results of the simulation was then revolved
to show the complete stent. It can be seen form Figure A.5, which indi-
cates the crimped state of the stent, that the stent performswell under the
crimping process. The design differs from the Edwards SAPIEN design
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Figure A.2: Stent Design 1: Crimped State
Figure A.3: Stent Design 1: Deployed State
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Figure A.4: Stent Design 2: Undeformed State
in that the support props extend well beyond the final row of stuts (See
Figure A.4). This is to allow for a maximum stent length, while prevent-
ing coronary obstruction from the stent. Maximizing the stent length is
advantageous as it allows for more room to seal the stent (which prevents
regurgitation), given the minimum required stent length to assemble the
valve leaflets. A simplified fatigue analysis was conducted of the pre-
dicted cyclic forces as experienced by the support props during the valve
operation (Details of the fatigue analysis are given in section 5.8). Figure
A.7 shows the maximum stress state of the fatigue analysis. The analysis
indicated that the safety factor against fatiguewas 1.15. Given that the re-
quired FSF was given as 1.5 (see section 3.1), this design did not conform
to the engineering requirements and was subsequently rejected. None
the less, the design served as the basis for further concept development.
A.3 Stent Concept: Design 3
The concept for Design 3 consists of a zig-zag strut pattern (along the
stent circumference) which has been duplicated and translated along the
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Figure A.5: Stent Design 2: Crimped State
Figure A.6: Stent Design 2: Deployed State
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Figure A.7: Stent Design 2: Fatigue Analysis
axial direction. The zig-zag strut patterns are inter-connectedwith straight
axial struts. The zig-zag strut pattern enables the crimping and expan-
sion of the stent, while the straight struts provide the structural sup-
port for the stent. Figure A.8 and Figure A.10 respectively shows the
undeformed initial geometry and fully expanded configuration of the
stent. Due to the cyclic radial symmetry of the stent, the initial expan-
sion, crimping and rigid deployment process was simulated for only one
twelth of the stent. The results of the simulation was then revolved to
show the complete stent. It can be seen form Figure A.9, which indi-
cates the crimped state of the stent, that the stent performs well under
the crimping process. The concept was more suitable for the parabolic
leaflets as compared to the straight leaflets. However, the strut alignment
at the deployed state was not ideal for a parabolic leaflet assembly. Given
the stent-leaflet slight incompatibility, the stent concept was rejected.
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Figure A.8: Stent Design 3: Undeformed State
Figure A.9: Stent Design 3: Crimped State
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Figure A.10: Stent Design 3: Deployed State
Appendix B
FEM Boundary Conditions
B.1 Concept A
The red element faces in Figure B.1 indicate the planes of cyclic sym-
metry for Concept A. The nodes in the planes of cyclic symmetry were
constrained to only allow for axial and radial translation in the symme-
try planes. The orange marker indicates the node that was subjected to
axial constraints to prevent the rigid body translation of the model.
B.2 Concept B
The red element faces in Figure B.2 indicate the planes of cyclic sym-
metry for Concept B. The nodes in the planes of cyclic symmetry were
constrained to only allow for axial and radial translation in the symme-
try planes. The orange marker indicates the node that was subjected to
axial constraints to prevent the rigid body translation of the model.
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Figure B.1: Concept A: Displacement Constraints
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Figure B.2: Concept B: Displacement Constraints
Appendix C
Concept B - Load Steps
Figure C.1: Assembly Expansion Load Step
Figure C.2: Crimping Load Step
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Figure C.3: Deployment Load Step
Appendix D
Electropolished Samples
Figure D.1 shows a magnified image of an untreated tubing sample. Fig-
ures D.2 to D.9 showsmagnified images of tubing samples that were elec-
tropolished, each with different parameters. The parameters that were
used for each sample is given in table D.1.
Figure D.1: Untreated Sample Figure D.2: Sample 1
Figure D.3: Sample 2 Figure D.4: Sample 3
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Figure D.5: Sample 4 Figure D.6: Sample 5
Figure D.7: Sample 6 Figure D.8: Sample 7
Figure D.9: Sample 8
Table D.1: Electropolished Sample Tubing: Parameters
Voltage Agitation Temperature Processing
(V) (Degrees) Time (s)
Sample 1 16 3/6 72 90
Sample 2 16 3/6 70 120
Sample 3 16 3/6 70 135
Sample 4 16 3/6 80 75
Sample 5 16 3/6 72 150
Sample 6 16 3/6 73 120
Sample 7 16 3/6 72 105
Sample 8 16 3/6 88 135
Appendix E
Fatigue Analysis: MATLAB Code
clear all
close all
%Load MSC.Marc Report File
load CoreValve_fatigue_020.rpt;
%Write File to Variable
data = CoreValve_fatigue_020(:,3);
%Declare Variables
%Number of Timesteps
Timesteps = 19;
%Number of Elements
Elements = length(data)/19;
%Fatigue Limit
sigma_e = 260;
%True Ultimate Tensile Strength
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sigma_ut = 965;
%Organise Data into Columns
for ii = 0:Elements - 1
for jj = 1:Timesteps
data1(jj,ii+1) = data(ii*9+jj);
end
end
%Get max and min principle stresses for each element
for ii = 1:Elements
max_prin_stress(ii) = max(data1(:,ii));
min_prin_stress(ii) = min(data1(:,ii));
end
%Calculate mean stress ans stress ampliture for each element
for ii = 1:Elements
stress_mean(ii) = (max_prin_stress(ii)+min_prin_stress(ii))/2;
stress_amp(ii) = abs((max_prin_stress(ii)-min_prin_stress(ii))/2);
end
%Ignore Elements in Compression
jj = 1;
for ii = 1:Elements
if stress_mean(ii) >= 0
stress_mean1(jj) = stress_mean(ii);
stress_amp1(jj) = stress_amp(ii);
jj = jj + 1;
end
end
%Calculate Modified Goodman line
m = -sigma_e/sigma_ut;
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x = 0:sigma_ut;
y = m*x + sigma_e;
%Calculate Data Point Nearest to Goodman Line
for ii = 1:length(stress_mean1)
c = stress_amp1(ii) - (-m)*stress_mean1(ii);
x1 = (c-260)/(2*m);
y1 = -m*x1+c;
dist(ii) = sqrt(((stress_amp1(ii)-y1)2ˆ+(stress_mean1(ii)-x1)2ˆ));
end
%Calculate min distance
min_dist = min(dist);
%Position of worst case data point
position = find(dist == min_dist);
%Worst Case Mean Stress
wc_stress_mean = stress_mean1(position)
%Worst Case Stress Amplitude
wc_stress_amp = stress_amp1(position)
%Get Worst Case Element Number
wc_Element = find(stress_mean == wc_stress_mean)
%Calculate Safety Factor Against Fatigue
SF = 1/((wc_stress_amp)/(260)+(wc_stress_mean)/(965))
%Plot Data and Write Figure to ’eps’ file
plot(stress_mean1,stress_amp1,’.’,’markersize’,4); %Plot Data
hold on
plot(x,y,’r’,’linewidth’,2);
grid on
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xlabel(’Predicted Mean Stress (MPa)’);
ylabel(’Predicted Stress Amplitude (MPa)’);
legend(’FEM Data’,’Modified Goodman Line’);
plot(wc_stress_mean,wc_stress_amp,’x’,’markersize’,6);
print(’-depsc’,’-r600’,’CoreValve020.eps’)
Appendix F
Fatigue Analysis: Results
0 100 200 300 400 500 600 700 800 900 1000
0
50
100
150
200
250
300
Predicted Mean Stress (MPa)
Pr
ed
ict
ed
 S
tre
ss
 A
m
pl
itu
de
 (M
Pa
)
 
 
FEM Data
Modified Goodman Line
Figure F.1: Concept A: Fatigue Diagram - Strut Width 0.20 mm
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Figure F.2: Concept A: Fatigue Diagram - Strut Width 0.25 mm
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Figure F.3: Concept A: Fatigue Diagram - Strut Width 0.27 mm
APPENDIX F. FATIGUE ANALYSIS: RESULTS 114
0 100 200 300 400 500 600 700 800 900 1000
0
50
100
150
200
250
300
Predicted Mean Stress (MPa)
Pr
ed
ict
ed
 S
tre
ss
 A
m
pl
itu
de
 (M
Pa
)
 
 
FEM Data
Modified Goodman Line
Figure F.4: Concept B: Fatigue Diagram - Strut Width 0.20 mm
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Figure F.5: Concept B: Fatigue Diagram - Strut Width 0.22 mm
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Figure F.6: Concept B: Fatigue Diagram - Strut Width 0.27 mm
Appendix G
Concept A: Second Iteration
Figure G.1 shows the suggested dimensions for the second iteration of
Concept A.
Figure G.1: Concept A: Second Iteration
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